Coexpression	O
of	O
the	O
interleukin-13	B-DNA
and	I-DNA
interleukin-4	I-DNA
genes	I-DNA
correlates	O
with	O
their	O
physical	O
linkage	O
in	O
the	O
cytokine	B-DNA
gene	I-DNA
cluster	I-DNA
on	O
human	B-DNA
chromosome	I-DNA
5q23-31	I-DNA
.	O

Interleukin-13	B-protein
(	O
IL-13	B-protein
)	O
and	O
IL-4	B-protein
are	O
cytokines	O
produced	O
by	O
T	O
cells	O
that	O
are	O
encoded	O
by	O
the	O
q23-31	O
region	O
of	O
human	O
chromosome	O
5	O
.	O

To	O
investigate	O
the	O
regulation	O
of	O
IL-13	B-DNA
gene	I-DNA
expression	O
by	O
T	B-cell_type
cells	I-cell_type
,	O
we	O
isolated	O
and	O
sequenced	O
the	O
human	O
IL-13	B-DNA
gene	I-DNA
,	O
analyzed	O
its	O
5'-flanking	B-DNA
region	I-DNA
for	O
potential	O
transcriptional	B-DNA
activation	I-DNA
elements	I-DNA
,	O
and	O
examined	O
its	O
expression	O
in	O
nontransformed	B-cell_line
T-lineage	I-cell_line
cell	I-cell_line
populations	I-cell_line
.	O

The	O
human	B-DNA
IL-13	I-DNA
gene	I-DNA
was	O
located	O
12.5-kb	B-DNA
upstream	I-DNA
of	O
the	O
IL-4	B-DNA
gene	I-DNA
and	O
2-kb	B-DNA
downstream	I-DNA
of	O
a	O
CpG	B-DNA
island	I-DNA
.	O

The	O
IL-13	B-DNA
gene	I-DNA
5	I-DNA
'	I-DNA
flank	I-DNA
region	I-DNA
included	O
a	O
segment	O
with	O
sequence	O
homology	O
to	O
P	B-DNA
elements	I-DNA
of	O
the	O
IL-4	B-DNA
promoter	I-DNA
involved	O
in	O
transcriptional	O
activation	O
in	O
T	B-cell_type
cells	I-cell_type
.	O

Mutation	O
of	O
the	O
IL-13	B-DNA
P	I-DNA
element	I-DNA
site	I-DNA
significantly	O
reduced	O
IL-13	B-protein
promoter	O
activity	O
in	O
response	O
to	O
T-cell	O
activation	O
.	O

Oligonucleotides	O
containing	O
the	O
IL-13	B-protein
or	O
IL-4	B-DNA
P	I-DNA
element	I-DNA
sites	I-DNA
specifically	O
bound	O
the	O
transcriptional	B-protein
activator	I-protein
protein	I-protein
,	O
nuclear	B-protein
factor-activated	I-protein
T	I-protein
cells	I-protein
,	O
preformed	O
(	O
NF-ATp	B-protein
)	O
,	O
when	O
incubated	O
with	O
nuclear	O
protein	O
extracts	O
from	O
activated	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Similar	O
to	O
IL-4	B-protein
,	O
IL-13	B-RNA
mRNA	I-RNA
expression	O
was	O
highest	O
in	O
T-cell	B-cell_line
populations	I-cell_line
enriched	O
for	O
cells	O
that	O
had	O
previously	O
been	O
primed	O
in	O
vivo	O
or	O
in	O
vitro	O
,	O
indicating	O
that	O
priming	O
increases	O
the	O
expression	O
of	O
the	O
IL-13	B-DNA
and	I-DNA
IL-4	I-DNA
genes	I-DNA
in	O
a	O
coordinate	O
manner	O
.	O

Because	O
the	O
primed	B-cell_line
T	I-cell_line
cells	I-cell_line
contain	O
higher	O
levels	O
of	O
nuclear	B-protein
NF-ATp	I-protein
,	O
capable	O
of	O
binding	O
to	O
P	B-DNA
elements	I-DNA
of	O
the	O
IL-4	B-DNA
and	I-DNA
IL-13	I-DNA
promoters	I-DNA
,	O
than	O
do	O
freshly-isolated	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
the	O
NF-AT-binding	B-DNA
P	I-DNA
elements	I-DNA
are	O
attractive	O
candidates	O
to	O
mediate	O
the	O
coordinate	O
expression	O
of	O
these	O
two	O
cytokine	B-DNA
genes	I-DNA
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Coexpression	NULL
of	NULL
the	NULL
Interleukin-13	NULL
and	NULL
Interleukin-4	NULL
Genes	NULL
Correlates	NULL
With	NULL
Their	NULL
Physical	NULL
Linkage	NULL
in	NULL
the	NULL
Cytokine	NULL
Gene	NULL
Cluster	NULL
on	NULL
Human	NULL
Chromosome	NULL
5q23-31	NULL
By	NULL
Gregory	NULL
Dolganov	NULL
,	NULL
Susan	NULL
Bort	NULL
,	NULL
Michael	NULL
Lovett	NULL
,	NULL
John	NULL
Burr	NULL
,	NULL
Lisa	NULL
Schubert	NULL
,	NULL
Douglas	NULL
Short	NULL
,	NULL
Mary	NULL
McGurn	NULL
,	NULL
Christine	NULL
Gibson	NULL
,	NULL
and	NULL
David	NULL
B.	NULL
Lewis	NULL
interleukin-13	NULL
(	NULL
IL-13	NULL
)	NULL
and	NULL
IL-4	NULL
are	NULL
cytokines	NULL
produced	NULL
by	NULL
T	NULL
cells	NULL
that	NULL
are	NULL
encoded	NULL
by	NULL
the	NULL
g23-31	NULL
region	NULL
of	NULL
human	NULL
chromosome	NULL
5	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
regulation	NULL
of	NULL
IL-13	NULL
gene	NULL
expression	NULL
by	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
isolated	NULL
and	NULL
sequenced	NULL
the	NULL
human	NULL
IL-13	NULL
gene	NULL
,	NULL
analyzed	NULL
its	NULL
5'-flanking	NULL
region	NULL
for	NULL
potential	NULL
transcriptional	NULL
activation	NULL
elements	NULL
,	NULL
and	NULL
examined	NULL
its	NULL
expression	NULL
in	NULL
nontransformed	NULL
T-lineage	NULL
cell	NULL
populations	NULL
.	NULL

The	NULL
human	NULL
IL-13	NULL
gene	NULL
was	NULL
located	NULL
12.5-kb	NULL
upstream	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
and	NULL
2-kb	NULL
downstream	NULL
of	NULL
a	NULL
CpG	NULL
island	NULL
.	NULL

The	NULL
IL-13	NULL
gene	NULL
5	NULL
'	NULL
flank	NULL
region	NULL
included	NULL
a	NULL
segment	NULL
with	NULL
sequence	NULL
homology	NULL
to	NULL
P	NULL
elements	NULL
of	NULL
the	NULL
IL-4	NULL
promoter	NULL
involved	NULL
in	NULL
transcriptional	NULL
activation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
IL-13	NULL
P	NULL
element	NULL
site	NULL
significantly	NULL
reduced	NULL
IL-13	NULL
promoter	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
the	NULL
IL-13	NULL
or	NULL
UMAN	NULL
T	NULL
CELLS	NULL
produce	NULL
a	NULL
number	NULL
of	NULL
cytokines	NULL
that	NULL
are	NULL
important	NULL
regulators	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
.	NULL

!	NULL

Many	NULL
of	NULL
these	NULL
proteins	NULL
are	NULL
encoded	NULL
on	NULL
chromosome	NULL
5q23-31	NULL
,	NULL
including	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
IL-9	NULL
,	NULL
IL-13	NULL
,	NULL
and	NULL
-	NULL
granulocyte-macrophage	NULL
-	NULL
colony-stimulating	NULL
-	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
*	NULL
``	NULL
whereas	NULL
others	NULL
,	NULL
such	NULL
as	NULL
IL-2	NULL
and	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
,	NULL
are	NULL
encoded	NULL
on	NULL
chromosomes	NULL
4	NULL
and	NULL
6	NULL
,	NULL
respec-tively	NULL
.	NULL
``	NULL

IL-13	NULL
was	NULL
first	NULL
reported	NULL
as	NULL
a	NULL
cytokine	NULL
transcript	NULL
preferentially	NULL
expressed	NULL
by	NULL
murine	NULL
T-cell	NULL
clones	NULL
of	NULL
the	NULL
Th	NULL
;	NULL
type	NULL
,	NULL
ie	NULL
,	NULL
producing	NULL
IL-4	NULL
but	NULL
not	NULL
IL-2	NULL
or	NULL
IFN-y	NULL
,	NULL
and	NULL
was	NULL
originally	NULL
called	NULL
p600.°°	NULL
Although	NULL
the	NULL
human	NULL
IL-4	NULL
and	NULL
IL-13	NULL
genes	NULL
are	NULL
only	NULL
about	NULL
20	NULL
%	NULL
to	NULL
30	NULL
%	NULL
homologous	NULL
at	NULL
the	NULL
amino	NULL
acid	NULL
level	NULL
,	NULL
``	NULL
``	NULL
they	NULL
share	NULL
a	NULL
striking	NULL
number	NULL
of	NULL
key	NULL
immunoregulatory	NULL
effects	NULL
.	NULL

Other	NULL
than	NULL
IL-4	NULL
,	NULL
IL-13	NULL
is	NULL
the	NULL
only	NULL
cytokine	NULL
known	NULL
that	NULL
promotes	NULL
IgE	NULL
isotype	NULL
switching	NULL
by	NULL
human	NULL
B	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
other	NULL
cytokines	NULL
.	NULL
``	NULL

Both	NULL
IL-13	NULL
and	NULL
IL-4	NULL
promote	NULL
growth	NULL
and	NULL
differentiation	NULL
of	NULL
normal	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
monocytes	NULL
,	NULL
``	NULL
inhibit	NULL
cytotoxicity	NULL
and	NULL
the	NULL
production	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
by	NULL
monocytes	NULL
,	NULL
'	NULL
``	NULL
``	NULL
°	NULL
and	NULL
increase	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
adhesion	NULL
molecule	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
on	NULL
endothelial	NULL
cells	NULL
.	NULL
``	NULL

However	NULL
,	NULL
IL-13	NULL
and	NULL
IL-4	NULL
also	NULL
differ	NULL
in	NULL
their	NULL
effects	NULL
From	NULL
Genelabs	NULL
Incorporated	NULL
,	NULL
Redwood	NULL
City	NULL
,	NULL
CA	NULL
;	NULL
the	NULL
Departments	NULL
of	NULL
Pediatrics	NULL
and	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
the	NULL
McDermott	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
,	NULL
Dallas	NULL
,	NULL
TX	NULL
.	NULL

Submitted	NULL
August	NULL
22	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
November	NULL
30	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
(	NULL
to	NULL
D.B.L	NULL
.	NULL

and	NULL
ML	NULL
.	NULL
)	NULL

and	NULL
the	NULL
March	NULL
of	NULL
Dimes	NULL
(	NULL
to	NULL
D.B.L	NULL
.	NULL
)	NULL

.	NULL

G.D.	NULL
and	NULL
S.B	NULL
.	NULL

contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
David	NULL
B.	NULL
Lewis	NULL
,	NULL
MD	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
Box	NULL
356320	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
98195	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
3316	NULL
IL-4	NULL
P	NULL
element	NULL
sites	NULL
specifically	NULL
bound	NULL
the	NULL
transcriptional	NULL
activator	NULL
protein	NULL
,	NULL
nuclear	NULL
factor-activated	NULL
T	NULL
cells	NULL
,	NULL
preformed	NULL
{	NULL
NF-ATp	NULL
)	NULL
,	NULL
when	NULL
incubated	NULL
with	NULL
nuclear	NULL
protein	NULL
extracts	NULL
from	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Similar	NULL
to	NULL
IL-4	NULL
,	NULL
IL-13	NULL
mRNA	NULL
expression	NULL
was	NULL
highest	NULL
in	NULL
T-cell	NULL
populations	NULL
enriched	NULL
for	NULL
cells	NULL
that	NULL
had	NULL
previously	NULL
been	NULL
primed	NULL
in	NULL
vivo	NULL
or	NULL
in	NULL
vitro	NULL
,	NULL
indicating	NULL
that	NULL
priming	NULL
increases	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
in	NULL
a	NULL
coordinate	NULL
manner	NULL
.	NULL

Because	NULL
the	NULL
primed	NULL
T	NULL
cells	NULL
contain	NULL
higher	NULL
levels	NULL
of	NULL
nuclear	NULL
NF-ATp	NULL
,	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
P	NULL
elements	NULL
of	NULL
the	NULL
IL-4	NULL
and	NULL
IL-13	NULL
promoters	NULL
,	NULL
than	NULL
do	NULL
freshly-isolated	NULL
T	NULL
ceils	NULL
,	NULL
the	NULL
NF-AT-binding	NULL
P	NULL
elements	NULL
are	NULL
attractive	NULL
candidates	NULL
to	NULL
mediate	NULL
the	NULL
coordinate	NULL
expression	NULL
of	NULL
these	NULL
two	NULL
cytokine	NULL
genes	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

on	NULL
certain	NULL
cell	NULL
types	NULL
.	NULL

For	NULL
example	NULL
,	NULL
IL-4	NULL
,	NULL
but	NULL
not	NULL
IL-13	NULL
,	NULL
promotes	NULL
the	NULL
growth	NULL
of	NULL
human	NULL
T-cell	NULL
blasts	NULL
and	NULL
clones	NULL
,	NULL
a	NULL
finding	NULL
that	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
lack	NULL
of	NULL
high-affinity	NULL
IL-13	NULL
receptors	NULL
on	NULL
T-lineage	NULL
cells	NULL
.	NULL
``	NULL

Human	NULL
IL-13	NULL
enhances	NULL
the	NULL
production	NULL
of	NULL
IFN-y	NULL
from	NULL
natural	NULL
killer	NULL
cells	NULL
by	NULL
itself	NULL
or	NULL
in	NULL
conjunction	NULL
with	NULL
IL-2	NULL
treatment	NULL
,	NULL
whereas	NULL
IL-4	NULL
is	NULL
inhibitory	NULL
in	NULL
this	NULL
situation	NULL
.	NULL

``	NULL
!	NULL

IL-13	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
synergizes	NULL
with	NULL
GM-CSF	NULL
in	NULL
promoting	NULL
colony	NULL
formation	NULL
by	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
although	NULL
there	NULL
is	NULL
considerable	NULL
overlap	NULL
in	NULL
the	NULL
effects	NULL
of	NULL
IL-4	NULL
and	NULL
IL-13	NULL
,	NULL
each	NULL
cytokine	NULL
may	NULL
also	NULL
have	NULL
a	NULL
distinct	NULL
role	NULL
in	NULL
regulating	NULL
T-cell-mediated	NULL
immune	NULL
responses	NULL
.	NULL

How	NULL
IL-13	NULL
expression	NULL
by	NULL
T	NULL
cells	NULL
is	NULL
controlled	NULL
at	NULL
the	NULL
cellular	NULL
and	NULL
molecular	NULL
level	NULL
is	NULL
poorly	NULL
understood	NULL
.	NULL

Previous	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
IL-13	NULL
mRNA	NULL
accumulation	NULL
is	NULL
induced	NULL
in	NULL
peripheral	NULL
blood	NULL
CD4	NULL
T	NULL
cells	NULL
by	NULL
treatment	NULL
with	NULL
anti-CD28	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
MoAbs	NULL
)	NULL
and	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
.	NULL
``	NULL

IL-13	NULL
and	NULL
IL-4	NULL
mRNA	NULL
are	NULL
both	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
some	NULL
murine	NULL
CD4	NULL
Th	NULL
;	NULL
-type	NULL
clones®	NULL
and	NULL
in	NULL
a	NULL
human	NULL
CD4	NULL
T-cell	NULL
clone	NULL
of	NULL
the	NULL
Th	NULL
,	NULL
-	NULL
type	NULL
(	NULL
ie	NULL
,	NULL
simultaneously	NULL
expressing	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IFN-y	NULL
)	NULL
,	NULL
``	NULL
suggesting	NULL
that	NULL
both	NULL
cytokine	NULL
genes	NULL
might	NULL
use	NULL
common	NULL
or	NULL
similar	NULL
mechanisms	NULL
for	NULL
transcription	NULL
.	NULL

However	NULL
,	NULL
the	NULL
temporal	NULL
pattern	NULL
of	NULL
IL-13	NULL
and	NULL
IL-4	NULL
mRNA	NULL
expression	NULL
differ	NULL
in	NULL
the	NULL
lung	NULL
tissue	NULL
of	NULL
mice	NULL
infected	NULL
with	NULL
the	NULL
Schistsoma	NULL
mansoni	NULL
,	NULL
``	NULL
indicating	NULL
that	NULL
expression	NULL
of	NULL
these	NULL
two	NULL
cytokine	NULL
genes	NULL
can	NULL
be	NULL
independently	NULL
regulated	NULL
under	NULL
some	NULL
conditions	NULL
in	NULL
vivo	NULL
.	NULL

Previous	NULL
physical	NULL
mapping	NULL
of	NULL
the	NULL
human	NULL
IL-13	NULL
gene	NULL
by	NULL
our	NULL
group*	NULL
and	NULL
others	NULL
``	NULL
has	NULL
shown	NULL
that	NULL
it	NULL
is	NULL
located	NULL
in	NULL
proximity	NULL
to	NULL
the	NULL
IL-4	NULL
and	NULL
IL-5	NULL
genes	NULL
in	NULL
the	NULL
5q23-31	NULL
region	NULL
.	NULL

To	NULL
begin	NULL
to	NULL
define	NULL
the	NULL
cellular	NULL
and	NULL
molecular	NULL
mechanisms	NULL
regulating	NULL
IL-13	NULL
gene	NULL
expression	NULL
by	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
have	NULL
isolated	NULL
and	NULL
sequenced	NULL
the	NULL
human	NULL
IL-13	NULL
gene	NULL
,	NULL
determined	NULL
its	NULL
precise	NULL
physical	NULL
location	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
IL-4	NULL
gene	NULL
,	NULL
analyzed	NULL
its	NULL
5	NULL
``	NULL
flanking	NULL
region	NULL
for	NULL
potential	NULL
transcriptional	NULL
activation	NULL
elements	NULL
,	NULL
and	NULL
have	NULL
examined	NULL
its	NULL
expression	NULL
by	NULL
nontransformed	NULL
human	NULL
T-lineage	NULL
cell	NULL
populations	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Isolation	NULL
and	NULL
DNA	NULL
sequence	NULL
analysis	NULL
of	NULL
IL-13	NULL
cDNA	NULL
and	NULL
genomic	NULL
clones	NULL
.	NULL

-	NULL
Human	NULL
IL-13	NULL
cDNA	NULL
fragments	NULL
,	NULL
clones	NULL
50-1	NULL
and	NULL
156	NULL
,	NULL
were	NULL
Blood	NULL
,	NULL
Vol	NULL
87	NULL
,	NULL
No	NULL
8	NULL
(	NULL
April	NULL
15	NULL
)	NULL
,	NULL
1996	NULL
:	NULL
pp	NULL
3316-3326	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

COEXPRESSION	NULL
OF	NULL
IL-4	NULL
AND	NULL
IL-13	NULL
€	NULL
_	NULL
—=	NULL
:	NULL
———	NULL
;	NULL
=—=_——	NULL
_	NULL
ES	NULL
po	NULL
g	NULL
mu	NULL
=	NULL
o	NULL
€	NULL
EEEEFEE	NULL
$	NULL
483	NULL
s	NULL
$	NULL
6	NULL
£	NULL
U	NULL
1	NULL
JC	NULL
4	NULL
|	NULL
|	NULL
L	NULL
OJ	NULL
LOU	NULL
1	NULL
Sequenced	NULL
Region	NULL
3317	NULL
CpG	NULL
-	NULL
island	NULL
&	NULL
©	NULL
&	NULL
=	NULL
=	NULL
S	NULL
Lox	NULL
=	NULL
_	NULL
TI	NULL
z	NULL
=	NULL
-	NULL
SS	NULL
$	NULL
550	NULL
frsfa	NULL
PG	NULL
to	NULL
Pf	NULL
ff	NULL
f	NULL
seee	NULL
A	NULL
C	NULL
2	NULL
0	NULL
S8	NULL
=	NULL
0	NULL
a	NULL
s	NULL
=	NULL
=	NULL
uo	NULL
o	NULL
us	NULL
T	NULL
u	NULL
®	NULL
IC	NULL
ad	NULL
c	NULL
in	NULL
-	NULL
wi	NULL
#	NULL
§	NULL
L	NULL
u	NULL
~*Y	NULL
%	NULL
_	NULL
_	NULL
|	NULL
iL	NULL
1	NULL
|__|	NULL
a_	NULL
I	NULL
I	NULL
1	NULL
23	NULL
4	NULL
|seDo	NULL
IL	NULL
13	NULL
|	NULL
|127Ds	NULL
]	NULL
0	NULL
10	NULL
kb	NULL
20	NULL
30	NULL
40	NULL
50	NULL
l	NULL
£	NULL
_L	NULL
LOLOL	NULL
OJ	NULL
_J	NULL
4	NULL
Ll	NULL
I	NULL
I	NULL
I	NULL
l	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
A	NULL
restriction	NULL
endonuclease	NULL
map	NULL
of	NULL
the	NULL
genomic	NULL
region	NULL
encompassing	NULL
human	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
.	NULL

Exons	NULL
are	NULL
indicated	NULL
in	NULL
black	NULL
.	NULL

Two	NULL
overlapping	NULL
cosmids	NULL
from	NULL
LANL	NULL
chromosome	NULL
5-specific	NULL
library	NULL
are	NULL
presented	NULL
with	NULL
their	NULL
coordinates	NULL
.	NULL

A	NULL
7.95-kb	NULL
BamtI	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
IL-13	NULL
gene	NULL
was	NULL
subcloned	NULL
as	NULL
two	NULL
Ecoftl-BamHI	NULL
fragments	NULL
and	NULL
sequenced	NULL
.	NULL

A	NULL
detailed	NULL
map	NULL
of	NULL
the	NULL
proposed	NULL
CpG	NULL
island	NULL
is	NULL
outlined	NULL
at	NULL
the	NULL
top	NULL
.	NULL

isolated	NULL
using	NULL
direct	NULL
selection	NULL
and	NULL
were	NULL
mapped	NULL
to	NULL
the	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
and	NULL
IL-5	NULL
genes	NULL
on	NULL
chromosome	NULL
5	NULL
as	NULL
previously	NULL
described	NULL
.	NULL

*	NULL
``	NULL
``	NULL
Human	NULL
chromosome	NULL
5-specific	NULL
cell	NULL
hybrids	NULL
,	NULL
``	NULL
``	NULL
IL-4-and	NULL
IL-5-containing	NULL
yeast	NULL
artificial	NULL
chromosomes	NULL
,	NULL
``	NULL
and	NULL
chromosome	NULL
5-specific	NULL
cosmids**	NULL
were	NULL
analyzed	NULL
by	NULL
Southern	NULL
blotting	NULL
using	NULL
these	NULL
cDNAs	NULL
as	NULL
probes	NULL
.	NULL

These	NULL
materials	NULL
or	NULL
human	NULL
genomic	NULL
DNA	NULL
were	NULL
also	NULL
analyzed	NULL
by	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
using	NULL
primers	NULL
derived	NULL
from	NULL
clone	NULL
50-1	NULL
(	NULL
coding	NULL
strand	NULL
primer	NULL
,	NULL
5	NULL
TGGCGC-TTTTGTTGACCAC	NULL
;	NULL
noncoding	NULL
strand	NULL
primer	NULL
,	NULL
SACAGTACAT-GCCAGCTGTCA	NULL
)	NULL
and	NULL
clone	NULL
156	NULL
(	NULL
coding	NULL
strand	NULL
primer	NULL
,	NULL
5'-CACTGGGCCCCATGGCGCTTT	NULL
;	NULL
noncoding	NULL
strand	NULL
primer	NULL
,	NULL
under	NULL
standard	NULL
conditions	NULL
at	NULL
an	NULL
annealing	NULL
temperature	NULL
of	NULL
50°C	NULL
.	NULL

A	NULL
6.95-kb	NULL
BamHUBamHI	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
IL-13	NULL
gene	NULL
was	NULL
subcloned	NULL
from	NULL
cosmid	NULL
58D9	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
into	NULL
the	NULL
vector	NULL
pBS	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
)	NULL
to	NULL
create	NULL
clone	NULL
10.4	NULL
and	NULL
was	NULL
sequenced	NULL
.	NULL

Genomic	NULL
or	NULL
cDNA	NULL
sequencing	NULL
was	NULL
performed	NULL
for	NULL
both	NULL
strands	NULL
of	NULL
each	NULL
clone	NULL
using	NULL
T7	NULL
Sequenase	NULL
2.0	NULL
kits	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
US	NULL
Biochemical	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

Sequence	NULL
assembly	NULL
and	NULL
analysis	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
software	NULL
package	NULL
(	NULL
Intelligenetics	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

A	NULL
portion	NULL
of	NULL
the	NULL
DNA	NULL
sequence	NULL
obtained	NULL
has	NULL
previously	NULL
been	NULL
identified	NULL
as	NULL
the	NULL
human	NULL
IL-13	NULL
gene	NULL
by	NULL
others	NULL
.	NULL
``	NULL

''	NULL
Human	NULL
IL-13	NULL
promoter	NULL
reporter	NULL
gene	NULL
constructs	NULL
and	NULL
transfection	NULL
.	NULL

A	NULL
0.98-kb	NULL
segment	NULL
of	NULL
the	NULL
human	NULL
IL-13	NULL
5°	NULL
flank	NULL
region	NULL
spanning	NULL
-940	NULL
to	NULL
+48	NULL
in	NULL
relation	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
from	NULL
the	NULL
human	NULL
IL-13	NULL
genomic	NULL
clone	NULL
10.2	NULL
using	NULL
the	NULL
primers	NULL
5'AGATGGATCCCAGAGACTGGTGAGCAAA	NULL
(	NULL
coding	NULL
strand	NULL
)	NULL
and	NULL
(	NULL
noncoding	NULL
strand	NULL
)	NULL
and	NULL
Vent	NULL
polymerase	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
,	NULL
Beverly	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

To	NULL
facilitate	NULL
subcloning	NULL
BamHI	NULL
and	NULL
HindIII	NULL
restriction	NULL
sites	NULL
were	NULL
included	NULL
in	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
coding	NULL
strand	NULL
and	NULL
noncoding	NULL
strand	NULL
primers	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
PCR	NULL
product	NULL
was	NULL
gel-purified	NULL
using	NULL
Suprec	NULL
columns	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Takara	NULL
,	NULL
Berkeley	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
was	NULL
digested	NULL
with	NULL
BamHI	NULL
and	NULL
HindIII	NULL
,	NULL
and	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
vector	NULL
,	NULL
pGL-2	NULL
Basic	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WD	NULL
)	NULL
,	NULL
to	NULL
create	NULL
the	NULL
final	NULL
plasmid	NULL
,	NULL
pIL-13/luc	NULL
.	NULL

PCR	NULL
by	NULL
overlap	NULL
extension	NULL
``	NULL
was	NULL
used	NULL
to	NULL
mutate	NULL
pIL-13/luc	NULL
at	NULL
the	NULL
P	NULL
element	NULL
site	NULL
at	NULL
-128	NULL
to	NULL
-119	NULL
from	NULL
the	NULL
sequence	NULL
GTGGAAAATC	NULL
to	NULL
GATATCAATC	NULL
(	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
noncoding	NULL
strand	NULL
is	NULL
shown	NULL
,	NULL
with	NULL
the	NULL
mutated	NULL
residues	NULL
indicated	NULL
in	NULL
bold	NULL
)	NULL
.	NULL

The	NULL
final	NULL
mutant	NULL
PCR	NULL
product	NULL
was	NULL
subcloned	NULL
into	NULL
pGL-2	NULL
basic	NULL
to	NULL
create	NULL
pIL-l3mut/luc	NULL
using	NULL
the	NULL
same	NULL
methods	NULL
as	NULL
for	NULL
the	NULL
pIL-13//uc	NULL
construct	NULL
.	NULL

DNA	NULL
sequencing	NULL
excluded	NULL
the	NULL
presence	NULL
of	NULL
any	NULL
PCR-related	NULL
errors	NULL
in	NULL
the	NULL
final	NULL
constructs	NULL
.	NULL

The	NULL
plasmid	NULL
pCMV//uc	NULL
(	NULL
pEQ-176	NULL
)	NULL
,	NULL
in	NULL
which	NULL
transcription	NULL
of	NULL
a	NULL
luciferase	NULL
cDNA	NULL
is	NULL
driven	NULL
by	NULL
the	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
)	NULL
immediate	NULL
early	NULL
gene	NULL
promoter	NULL
,	NULL
``	NULL
``	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
con-trol	NULL
.	NULL

Large-scale	NULL
preparations	NULL
of	NULL
these	NULL
plasmids	NULL
were	NULL
prepared	NULL
using	NULL
Nucleobond	NULL
Ax	NULL
columns	NULL
(	NULL
Nest	NULL
Group	NULL
,	NULL
Southboro	NULL
,	NULL
MA	NULL
)	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

For	NULL
each	NULL
construct	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
plasmid	NULL
DNA	NULL
was	NULL
electroporated	NULL
into	NULL
12	NULL
x	NULL
10°	NULL
Jurkat	NULL
thymoma	NULL
cells	NULL
(	NULL
pro-vided	NULL
by	NULL
Dr	NULL
C.	NULL
Wilson	NULL
,	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
in	NULL
0.4	NULL
mL	NULL
of	NULL
RPMI	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
medium	NULL
using	NULL
4-mm	NULL
electroporation	NULL
cuvettes	NULL
and	NULL
an	NULL
Electro	NULL
Cell	NULL
Manipulator	NULL
600	NULL
electro-porator	NULL
(	NULL
BTX	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
settings	NULL
of	NULL
260	NULL
V	NULL
and	NULL
1,050	NULL
micro-farads	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
diluted	NULL
to	NULL
a	NULL
concentration	NULL
of	NULL
1	NULL
x	NULL
10°/mL	NULL
in	NULL
fresh	NULL
medium	NULL
and	NULL
placed	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
tissue	NULL
culture	NULL
incubator	NULL
for	NULL
6	NULL
hours	NULL
.	NULL

After	NULL
incubation	NULL
,	NULL
aliquots	NULL
of	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
6.5	NULL
pg/mL	NULL
concanavalin	NULL
A	NULL
(	NULL
Con	NULL
A	NULL
;	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
10	NULL
ng/mL	NULL
PMA	NULL
(	NULL
Sigma	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
or	NULL
were	NULL
left	NULL
untreated	NULL
for	NULL
an	NULL
additional	NULL
16	NULL
hours	NULL
at	NULL
37°C	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
;	NULL
Sandoz	NULL
,	NULL
Basel	NULL
,	NULL
Switzerland	NULL
)	NULL
was	NULL
added	NULL
1	NULL
hour	NULL
before	NULL
stimulation	NULL
at	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
500	NULL
ng/mL	NULL
.	NULL

Cells	NULL
were	NULL
then	NULL
harvested	NULL
by	NULL
centrifugation	NULL
,	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
,	NULL
dissolved	NULL
in	NULL
reporter	NULL
lysis	NULL
buffer	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
as	NULL
directed	NULL
by	NULL
the	NULL
manufacturer	NULL
,	NULL
and	NULL
stored	NULL
at	NULL
-80°C	NULL
until	NULL
assayed	NULL
.	NULL

Lysates	NULL
were	NULL
thawed	NULL
to	NULL
room	NULL
temperature	NULL
,	NULL
diluted	NULL
5-fold	NULL
in	NULL
luciferase	NULL
assay	NULL
buffer	NULL
(	NULL
Promega	NULL
)	NULL
,	NULL
and	NULL
analyzed	NULL
in	NULL
duplicate	NULL
for	NULL
luciferase	NULL
activity	NULL
for	NULL
30	NULL
seconds	NULL
using	NULL
a	NULL
Monolight	NULL
1500	NULL
luminometer	NULL
(	NULL
Analytical	NULL
Luminescence	NULL
Laboratory	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

T-cell	NULL
isolation	NULL
,	NULL
priming	NULL
,	NULL
and	NULL
cloning	NULL
.	NULL

-	NULL
Circulating	NULL
adult	NULL
and	NULL
neonatal	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
isolated	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

To	NULL
isolate	NULL
neonatal	NULL
CD4	NULL
T	NULL
cells	NULL
or	NULL
adult	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
circulating	NULL
whole	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3318	NULL
mononuclear	NULL
cells	NULL
(	NULL
WMC	NULL
's	NULL
)	NULL
were	NULL
purified	NULL
by	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
centrifugation	NULL
and	NULL
treated	NULL
with	NULL
CD4	NULL
Lymphokwik	NULL
(	NULL
One	NULL
Lambda	NULL
,	NULL
Los	NULL
Angeles	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
a	NULL
proprietary	NULL
mixture	NULL
of	NULL
complement	NULL
and	NULL
MoAbs	NULL
directed	NULL
against	NULL
non-T-lineage	NULL
and	NULL
CD8	NULL
surface	NULL
markers	NULL
,	NULL
following	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

The	NULL
CD45RA~	NULL
(	NULL
CD45RO*	NULL
)	NULL
cell	NULL
subset	NULL
was	NULL
purified	NULL
from	NULL
adult	NULL
CD4	NULL
T	NULL
cells	NULL
using	NULL
anti-CD45RA	NULL
MoAb	NULL
,	NULL
3AC5*	NULL
,	NULL
and	NULL
an	NULL
indirect	NULL
panning	NULL
technique	NULL
to	NULL
deplete	NULL
CD4SRA	NULL
*	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

'	NULL
The	NULL
final	NULL
purity	NULL
of	NULL
each	NULL
T-lineage	NULL
cell	NULL
population	NULL
was	NULL
routinely	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
pure	NULL
based	NULL
on	NULL
flow	NULL
cytometric	NULL
analysis	NULL
after	NULL
staining	NULL
with	NULL
appropriate	NULL
MoAbs	NULL
.	NULL

To	NULL
prime	NULL
CD4	NULL
T	NULL
cells	NULL
in	NULL
vitro	NULL
,	NULL
freshly	NULL
isolated	NULL
adult	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
placed	NULL
at	NULL
1	NULL
to	NULL
2	NULL
x	NULL
10	NULL
%	NULL
/mL	NULL
into	NULL
12-well	NULL
flat	NULL
bottom	NULL
plates	NULL
(	NULL
Corning	NULL
,	NULL
Corning	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

Each	NULL
well	NULL
contained	NULL
1	NULL
to	NULL
2	NULL
x	NULL
10°	NULL
%	NULL
/mL	NULL
irradiated	NULL
adult	NULL
WMC	NULL
's	NULL
(	NULL
30	NULL
Gy	NULL
)	NULL
in	NULL
2	NULL
mL	NULL
of	NULL
CT.4S	NULL
medium	NULL
``	NULL
supplemented	NULL
with	NULL
3.1	NULL
ug/mL	NULL
of	NULL
Con	NULL
A	NULL
,	NULL
0.5	NULL
ng/mL	NULL
of	NULL
PMA	NULL
,	NULL
5	NULL
U/	NULL
mL	NULL
purified	NULL
human	NULL
IL-2	NULL
(	NULL
Boehringer-Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
,	NULL
and	NULL
5	NULL
ng/mL	NULL
of	NULL
recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
K.	NULL
Grabstein	NULL
,	NULL
Immunex	NULL
Corp	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

Overlying	NULL
medium	NULL
(	NULL
0.5	NULL
mL	NULL
)	NULL
was	NULL
replaced	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
fresh	NULL
CT.4S	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
U/mL	NULL
of	NULL
IL-2	NULL
every	NULL
3	NULL
days	NULL
.	NULL

Viable	NULL
cells	NULL
were	NULL
harvested	NULL
by	NULL
Ficoll-Hypaque	NULL
centrifugation	NULL
after	NULL
2	NULL
to	NULL
3	NULL
weeks	NULL
.	NULL

To	NULL
isolate	NULL
T-cell	NULL
clones	NULL
by	NULL
direct	NULL
limiting	NULL
dilution	NULL
,	NULL
purified	NULL
adult	NULL
or	NULL
neonatal	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
seeded	NULL
at	NULL
1	NULL
or	NULL
5	NULL
cells	NULL
per	NULL
well	NULL
into	NULL
96-well	NULL
round	NULL
bottom	NULL
plates	NULL
(	NULL
Corning	NULL
)	NULL
.	NULL

Each	NULL
well	NULL
contained	NULL
100,000	NULL
irradiated	NULL
adult	NULL
WMCs	NULL
(	NULL
30	NULL
Gy	NULL
)	NULL
in	NULL
CT.4S	NULL
medium	NULL
supplemented	NULL
with	NULL
3.1	NULL
ug/mL	NULL
of	NULL
Con	NULL
A	NULL
,	NULL
0.5	NULL
ng/mL	NULL
of	NULL
PMA	NULL
,	NULL
5	NULL
U/mL	NULL
purified	NULL
human	NULL
IL-2	NULL
,	NULL
and	NULL
5	NULL
ng/mL	NULL
of	NULL
recombinant	NULL
human	NULL
IL-2	NULL
.	NULL

Overlying	NULL
medium	NULL
(	NULL
0.1	NULL
mL	NULL
)	NULL
was	NULL
replaced	NULL
with	NULL
an	NULL
equal	NULL
volume	NULL
of	NULL
fresh	NULL
CT.4S	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
U/mL	NULL
of	NULL
IL-2	NULL
every	NULL
3	NULL
to	NULL
5	NULL
days	NULL
.	NULL

After	NULL
3	NULL
to	NULL
4	NULL
weeks	NULL
,	NULL
growth-positive	NULL
wells	NULL
were	NULL
scored	NULL
microscopically	NULL
and	NULL
expanded	NULL
in	NULL
12-well	NULL
tissue	NULL
culture	NULL
plates	NULL
by	NULL
restimulation	NULL
with	NULL
Con	NULL
A	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
irradiated	NULL
WMCs	NULL
every	NULL
2	NULL
to	NULL
3	NULL
weeks	NULL
.	NULL

Wells	NULL
with	NULL
growth	NULL
after	NULL
seeding	NULL
with	NULL
5	NULL
cells	NULL
were	NULL
expanded	NULL
only	NULL
if	NULL
less	NULL
than	NULL
20	NULL
%	NULL
of	NULL
such	NULL
wells	NULL
scored	NULL
positive	NULL
.	NULL

Viable	NULL
clone	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
Ficoll-Hypaque	NULL
density	NULL
gradient	NULL
centrifugation	NULL
and	NULL
were	NULL
extensively	NULL
washed	NULL
before	NULL
use	NULL
.	NULL

Cell	NULL
activation	NULL
,	NULL
.	NULL

-	NULL
Cells	NULL
were	NULL
activated	NULL
at	NULL
5	NULL
X	NULL
10	NULL
%	NULL
/mL	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
human	NULL
AB	NULL
serum	NULL
as	NULL
previously	NULL
described	NULL
``	NULL
'	NULL
using	NULL
50	NULL
ng/mL	NULL
PMA	NULL
in	NULL
combination	NULL
with	NULL
either	NULL
25	NULL
ug/	NULL
mL	NULL
Con	NULL
A	NULL
or	NULL
0.5	NULL
pmol/L	NULL
ionomycin	NULL
(	NULL
Calbiochem-Behring	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

We	NULL
used	NULL
these	NULL
two	NULL
activation	NULL
conditions	NULL
because	NULL
they	NULL
reliably	NULL
induced	NULL
high	NULL
levels	NULL
of	NULL
IL-13	NULL
mRNA	NULL
,	NULL
whereas	NULL
other	NULL
stimuli	NULL
,	NULL
such	NULL
as	NULL
anti-CD3	NULL
MoAb	NULL
in	NULL
combination	NULL
with	NULL
PMA	NULL
,	NULL
were	NULL
much	NULL
less	NULL
effective	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Nuclear	NULL
protein	NULL
preparations	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
.	NULL

_	NULL
CD4	NULL
T	NULL
cells	NULL
previously	NULL
primed	NULL
in	NULL
vitro	NULL
for	NULL
2	NULL
to	NULL
3	NULL
weeks	NULL
were	NULL
stimulated	NULL
for	NULL
2	NULL
hours	NULL
with	NULL
Con	NULL
A	NULL
(	NULL
25	NULL
ng/mL	NULL
)	NULL
and	NULL
PMA	NULL
(	NULL
25	NULL
ng/mL	NULL
)	NULL
,	NULL
and	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
as	NULL
described	NULL
by	NULL
Penix	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
Nuclear	NULL
protein	NULL
extracts	NULL
(	NULL
3	NULL
to	NULL
4	NULL
ug	NULL
)	NULL
were	NULL
preincu-bated	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
50	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mmoV/L	NULL
dithio-threitol	NULL
,	NULL
2	NULL
mmol/L	NULL
pefabloc	NULL
[	NULL
Boehringer-Mannheim	NULL
]	NULL
,	NULL
2	NULL
pg/mL	NULL
pep-statin	NULL
A	NULL
[	NULL
Calbiochem	NULL
]	NULL
,	NULL
and	NULL
1	NULL
ug	NULL
of	NULL
polydI-dC	NULL
[	NULL
Pharmacia	NULL
]	NULL
)	NULL
and	NULL
oligonucleotide	NULL
competitors	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

Probe	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cpm	NULL
)	NULL
was	NULL
then	NULL
added	NULL
to	NULL
a	NULL
final	NULL
volume	NULL
of	NULL
25	NULL
LL	NULL
,	NULL
and	NULL
the	NULL
incubation	NULL
was	NULL
continued	NULL
for	NULL
an	NULL
additional	NULL
15	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

In	NULL
some	NULL
reactions	NULL
,	NULL
the	NULL
nuclear	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
1	NULL
L	NULL
of	NULL
rabbit	NULL
antisera	NULL
raised	NULL
against	NULL
the	NULL
NF-ATp	NULL
peptide	NULL
72	NULL
``	NULL
(	NULL
QLVPAIPICSIPV-TASLPPLEWPLSNQ	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
on	NULL
ice	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
the	NULL
antisera	NULL
were	NULL
first	NULL
incubated	NULL
with	NULL
0.5	NULL
uL	NULL
(	NULL
500	NULL
ng	NULL
)	NULL
of	NULL
either	NULL
peptide	NULL
72	NULL
or	NULL
with	NULL
,	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
another	NULL
NF-ATp-derived	NULL
peptide	NULL
,	NULL
peptide	NULL
48	NULL
``	NULL
(	NULL
SAHELPMVERQDMDS-CLVYGGQQ	NULL
)	NULL
for	NULL
30	NULL
minutes	NULL
on	NULL
ice	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
nuclear	NULL
protein	NULL
.	NULL

NF-ATp-specific	NULL
antiserum	NULL
and	NULL
peptides	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Dr	NULL
A.	NULL
Rao	NULL
(	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Bos-	NULL
DOLGANOYV	NULL
ET	NULL
AL	NULL
ton	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

All	NULL
reactions	NULL
were	NULL
analyzed	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electro-phoresis	NULL
at	NULL
room	NULL
temperature	NULL
using	NULL
4	NULL
%	NULL
gels	NULL
in	NULL
0.027	NULL
mol/L	NULL
Tris-borate	NULL
,	NULL
0.6	NULL
mmol/L	NULL
EDTA	NULL
buffer	NULL
.	NULL

Oligonucleotides	NULL
for	NULL
EMSAs	NULL
.	NULL

-	NULL
Oligonucleotides	NULL
were	NULL
synthesized	NULL
by	NULL
the	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
(	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

The	NULL
following	NULL
double-stranded	NULL
oligonucleotides	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
and	NULL
unlabeled	NULL
competitors	NULL
(	NULL
in	NULL
each	NULL
case	NULL
,	NULL
only	NULL
the	NULL
noncoding	NULL
strand	NULL
is	NULL
shown	NULL
)	NULL
:	NULL
hIL-4	NULL
promoter	NULL
P1	NULL
element	NULL
(	NULL
-66	NULL
to	NULL
-82	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
)	NULL
,	NULL
``	NULL
ATTGGAAATTTTCGTTA	NULL
;	NULL
mutant	NULL
hIL-4	NULL
promoter	NULL
PI	NULL
element	NULL
,	NULL
ATTATAAATTTTCGTTA	NULL
;	NULL
hIL-13	NULL
promoter	NULL
P	NULL
element-like	NULL
site	NULL
(	NULL
-134	NULL
to	NULL
-149	NULL
)	NULL
,	NULL
TGTGGAAAATCCAGTG	NULL
;	NULL
mutant	NULL
hIL-13	NULL
promoter	NULL
P	NULL
element-like	NULL
site	NULL
,	NULL
TGTGGTCAATC-CAGTG	NULL
.	NULL

Residues	NULL
that	NULL
are	NULL
mutated	NULL
from	NULL
the	NULL
wild-type	NULL
sequences	NULL
are	NULL
indicated	NULL
in	NULL
bold	NULL
.	NULL

For	NULL
each	NULL
probe	NULL
used	NULL
in	NULL
EMSA	NULL
,	NULL
complementary	NULL
oligonucleotide	NULL
strands	NULL
were	NULL
separately	NULL
end-labeled	NULL
with	NULL
y-*P-aden-osine	NULL
triphosphate	NULL
using	NULL
T4	NULL
kinase	NULL
and	NULL
were	NULL
annealed	NULL
,	NULL
and	NULL
the	NULL
double-stranded	NULL
probe	NULL
was	NULL
purified	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophore-sis	NULL
using	NULL
10	NULL
%	NULL
nondenaturing	NULL
gels	NULL
.	NULL

RNA	NULL
blotting	NULL
and	NULL
hybridization	NULL
.	NULL

-	NULL
Total	NULL
RNA	NULL
was	NULL
isolated	NULL
by	NULL
the	NULL
guanidinium	NULL
isothiocyanate/CsCl	NULL
method	NULL
``	NULL
``	NULL
or	NULL
by	NULL
the	NULL
acid	NULL
guanidinium	NULL
isothiocyanate-phenol-chloroform	NULL
extraction	NULL
method	NULL
``	NULL
``	NULL
using	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
Trireagent	NULL
;	NULL
Molecular	NULL
Research	NULL
Center	NULL
,	NULL
Cincinnati	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
blotted	NULL
,	NULL
hybridized	NULL
with	NULL
``	NULL
P-labeled	NULL
RNA	NULL
or	NULL
DNA	NULL
probes	NULL
,	NULL
and	NULL
washed	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

The	NULL
full-length	NULL
human	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
elongation	NULL
factor-la	NULL
(	NULL
EF-1	NULL
@	NULL
)	NULL
probes	NULL
have	NULL
been	NULL
described	NULL
.	NULL
``	NULL

The	NULL
human	NULL
IL-13	NULL
cDNA	NULL
probe	NULL
was	NULL
derived	NULL
from	NULL
a	NULL
full-length	NULL
cDNA	NULL
clone	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
consisted	NULL
of	NULL
nucleotides	NULL
11	NULL
to	NULL
263	NULL
.	NULL
``	NULL

All	NULL
probes	NULL
consisted	NULL
of	NULL
DNA	NULL
labeled	NULL
by	NULL
the	NULL
random	NULL
hexamer	NULL
priming	NULL
method	NULL
``	NULL
``	NULL
using	NULL
a	NULL
commercial	NULL
kit	NULL
(	NULL
Pharmacia	NULL
)	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
the	NULL
IL-4	NULL
probe	NULL
,	NULL
for	NULL
which	NULL
a	NULL
single-stranded	NULL
RNA	NULL
probe	NULL
was	NULL
used	NULL
.	NULL
``	NULL

RESULTS	NULL
Organization	NULL
of	NULL
human	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
reported	NULL
the	NULL
isolation	NULL
of	NULL
several	NULL
human	NULL
cDNA	NULL
clones	NULL
highly	NULL
homologous	NULL
to	NULL
the	NULL
cytokine	NULL
encoded	NULL
by	NULL
the	NULL
murine	NULL
IL-13	NULL
(	NULL
p600	NULL
)	NULL
cDNA	NULL
using	NULL
a	NULL
direct	NULL
selection	NULL
method	NULL
.	NULL

*	NULL
Using	NULL
these	NULL
cDNAs	NULL
as	NULL
probes	NULL
,	NULL
we	NULL
isolated	NULL
two	NULL
human	NULL
cosmids	NULL
that	NULL
each	NULL
encompass	NULL
the	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genetic	NULL
loci	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

Mapping	NULL
using	NULL
restriction	NULL
enzymes	NULL
showed	NULL
that	NULL
the	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
were	NULL
separated	NULL
by	NULL
about	NULL
12	NULL
kb	NULL
.	NULL

A	NULL
6.95-kb	NULL
BamHI	NULL
fragment	NULL
containing	NULL
the	NULL
IL-13	NULL
gene	NULL
was	NULL
subcloned	NULL
from	NULL
one	NULL
of	NULL
these	NULL
cosmids	NULL
,	NULL
58D9	NULL
,	NULL
and	NULL
was	NULL
completely	NULL
sequenced	NULL
.	NULL

*	NULL
This	NULL
showed	NULL
that	NULL
a	NULL
CpG	NULL
island	NULL
,	NULL
based	NULL
on	NULL
its	NULL
high	NULL
G/C	NULL
content	NULL
,	NULL
``	NULL
``	NULL
was	NULL
located	NULL
2-kb	NULL
upstream	NULL
of	NULL
the	NULL
IL-13	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
Figs	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
restriction	NULL
mapping	NULL
with	NULL
rare	NULL
cutting	NULL
endonucleases	NULL
,	NULL
we	NULL
did	NULL
not	NULL
find	NULL
evidence	NULL
of	NULL
any	NULL
additional	NULL
CpG	NULL
island	NULL
regions	NULL
in	NULL
cosmid	NULL
58D9	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
those	NULL
previously	NULL
reported	NULL
for	NULL
the	NULL
human	NULL
IL-13	NULL
cDNA	NULL
``	NULL
and	NULL
for	NULL
a	NULL
more	NULL
limited	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-13	NULL
gene	NULL
.	NULL
``	NULL

The	NULL
human	NULL
IL-13	NULL
gene	NULL
had	NULL
a	NULL
4-exon-3-intron	NULL
structure	NULL
found	NULL
in	NULL
the	NULL
IL-4	NULL
gene	NULL
and	NULL
most	NULL
other	NULL
T-cell-derived	NULL
cytokines	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
the	NULL
results	NULL
of	NULL
others	NULL
,	NULL
``	NULL
``	NULL
we	NULL
found	NULL
that	NULL
the	NULL
predicted	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
of	NULL
IL-13	NULL
mRNA	NULL
contained	NULL
multiple	NULL
AUUA	NULL
sequences	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
that	NULL
have	NULL
been	NULL
observed	NULL
in	NULL
all	NULL
T-cell-derived	NULL
cytokine	NULL
genes	NULL
to	NULL
date	NULL
and	NULL
appear	NULL
to	NULL
confer	NULL
mRNA	NULL
instability	NULL
.	NULL
``	NULL

Our	NULL
analysis	NULL
also	NULL
showed	NULL
that	NULL
the	NULL
human	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
are	NULL
in	NULL
the	NULL
same	NULL
*	NULL
This	NULL
sequence	NULL
is	NULL
available	NULL
via	NULL
Genebank	NULL
Accession	NULL
No	NULL
.	NULL

U31	NULL
120	NULL
.	NULL

COEXPRESSION	NULL
OF	NULL
IL-4	NULL
AND	NULL
I1L-13	NULL
-2159	NULL
-2079	NULL
-1999	NULL
-1919	NULL
-1839	NULL
-1759	NULL
-1679	NULL
-1599	NULL
-1519	NULL
-1439	NULL
-1359	NULL
-1279	NULL
-1199	NULL
-1119	NULL
-1039	NULL
-959	NULL
-879	NULL
-199	NULL
-=719	NULL
-639	NULL
-559	NULL
-479	NULL
-399	NULL
-319	NULL
-~239	NULL
-~159	NULL
-79	NULL
+1	NULL
Fig	NULL
2	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3319	NULL
BamHI	NULL
Xbal	NULL
GGATCCCCGCTGACAATCTAGAAACAAGCAACAGACCCTCTGATGTAGCCATCTGTGCCGCGCCTCTCCGCACCGCcccec	NULL
CACGCCTTGGTCCCTGGAGACCACCCTCCAGGGCAGGGGCTGCCGCTCGGCCGGGCCCGCGGGGTCCCTCGGCCTGACAT	NULL
AGCCGCTGGCCCGGGTGTCCAGCCGGCCCTPCCCCTéCCTGeccecTCcGeGacceCccAaccrTreccecccccrceccaoGccTt	NULL
CCGCAGCTTCCAGACTGGCCGGTCTGCGCGCCCACCCCTGCCTCCCGGACCGGCCACCGCCGAGGCCGCGGAGGAGGGCC	NULL
CGGCCGCGCAGATCCCGCTTATCGGGCCCCATCTCCCGTTACATAAGGCCACCCCCCTATCTCCGCGGGCCATCGCCGCC	NULL
GGGGATAAGGGGCGTTGACTCACCCGGGCGGGGCTCCGGGAGTTGCACAGACCAAGGTAGTTCCCCGCTCCTTCCCCCAT	NULL
CACGGAGACCCTGTGGGAGATGCCGTGGGCCCTCTACTACAGATTAGGAAACAGGCCCGTAGAGGGGTCGCGCGGCCAAG	NULL
TAGCGGCACTCCAGGCACTGGGGGCCCTCéggéGAAGGGGCAGACTTCTGGGAGTCAGAGCCAGCAGCTGGGCTGGGAAG	NULL
CTTCGAGTGTGGACAGAGAGCGCGTGGGAATGACGTTCCCTGTGGGAAGAGAGGGTGGGCAAGCCTGGGATGCCTCTGAGCG	NULL
GGAATCCAGCATGCCTTGTGAGGAGGGTCACAAGCACACCCTTGTGAGGAGGTTGAGCCCCATCGAGGACAGCGACGGAGG	NULL
GAGCCTGAGCAGGCAGAGAGGGGGCCTGGGGAGGCGCTGGTTCGGGGAGCAAGTGGGTAGGGGAGAAATCTTGACATCAA	NULL
CACCCAACAGGCAAATGCCGTGGCCTCTGCTGTGGGGGTTTCTGGAGGACTTCTAGCAAAACGACGCGAAGAGCAGGAAAA	NULL
GGCGACATGGCTGTAGGGCCAAGCCCAGGAGCCGCCCTCCACAGCACTCATTCTGCAGAAGGCGAAATTTGAGGCCCCCAG	NULL
ACGGCAGGGGTTGATCCTGCAGAGACTGGTGAGCAAAGGCGCATCACCCCAAGCCCCAGTGCGCACTAGGAACACTTACAAT	NULL
CTCTGACCTGGACTAAGGCTGCCAGCCTGGCCCAGTTAAGAGTTTCCCAGAAGGATGGCCCATACACTTTAAATTAAAGG	NULL
GGCCAGACACGTGCACACTACTTCCAGCCACTCTGGAAGCTGAGGTGGGGGCGATCGCTTGAGTCTGGGAGTTGGAGGCCA	NULL
GCCTGGCAGGCAACATAGTGAGACCCCATCTCCAAAAAAACAAAACAAAAACAAAACAAAAAAACACCAAAAAAGCTCCC	NULL
AGAAAGACCTCTGAATCTTTCTGGATCTCTCAGTGGAGAACCTGGAAAATCTGAACTTTGACAATCCCTCTCACAGTGGG	NULL
GGCCAAGGAGGAATTAGGCAAGCCAAAAGAAGTGAACTTTACTCTTCTATTGCCTGTTTGAATTTTGTATCCAAGCAAGT	NULL
GTTACTTAAGTAATTTAAGAGACTGGTTCATCGAAAAAATAAAACTCCCCAAATTCCCATAGCTGGTAGACTCTGGTCAC	NULL
AGCCACAGTGCACTAAGACTATCTGCTCAGCACTTCTGGTGACCCAAAAGCGCGTCTGAGGACAGGAGCTCAGAGTTGGGTC	NULL
AGCTGTCCAGGTACTCAGGCTTGTCACAGGCAAAACTGCTGGAACTCAGGGCAGCATTGCAAATGCCACGCCGCTCTCAG	NULL
GGCCCCTTGCCTGCCGCTGGAATTAAACCCACCCAGATCTTGGAAACTCTGCCCTGGACCCTTCTCAATAAGTCCATGAG	NULL
AAATCAAACTCTTTCCTTTATGCGACACTGGATTTTCCACAAAGTAAAATCAAGATGAGTAAAGATGTGGTTTCTAGATA	NULL
#	NULL
te	NULL
ote	NULL
e	NULL
tk	NULL
GTGCCTGAAAAAGCACGAGACCATGGTGTCAGGCGTCACCACTTGGGCCTATAAAAGCTGCCACAAGACGCCAAGGCCACA	NULL
AAGCCACCCAGCCTATGCATCCGCTCCTCAATCCTCTCCTGTTGGCACTGGGCCTCATG	NULL
The	NULL
5	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-13	NULL
gene	NULL
.	NULL

The	NULL
CpG	NULL
island	NULL
region	NULL
located	NULL
between	NULL
-2159	NULL
to	NULL
-718	NULL
is	NULL
indicated	NULL
in	NULL
bold	NULL
.	NULL

A	NULL
purine-	NULL
rich	NULL
sequence	NULL
{	NULL
noncoding	NULL
strand	NULL
)	NULL
at	NULL
-129	NULL
to	NULL
-122	NULL
with	NULL
homology	NULL
to	NULL
IL-4	NULL
promoter	NULL
P	NULL
element	NULL
sequences	NULL
is	NULL
in	NULL
bold	NULL
and	NULL
underlined	NULL
.	NULL

A	NULL
TATA	NULL
box	NULL
is	NULL
indicated	NULL
by	NULL
overlying	NULL
asterisks	NULL
.	NULL

The	NULL
presumed	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
assigned	NULL
+1	NULL
,	NULL
and	NULL
the	NULL
initiator	NULL
codon	NULL
at	NULL
+56	NULL
,	NULL
indicated	NULL
in	NULL
italics	NULL
,	NULL
have	NULL
been	NULL
previously	NULL
reported	NULL
by	NULL
others	NULL
.	NULL

B11	NULL
transcriptional	NULL
orientation	NULL
.	NULL

Whether	NULL
the	NULL
few	NULL
discrepancies	NULL
of	NULL
The	NULL
5	NULL
'	NULL
flank	NULL
region	NULL
of	NULL
the	NULL
IL-13	NULL
gene	NULL
contains	NULL
a	NULL
putative	NULL
our	NULL
sequence	NULL
that	NULL
differ	NULL
from	NULL
those	NULL
previously	NULL
published	NULL
for	NULL
P	NULL
element	NULL
sequence	NULL
that	NULL
contributes	NULL
to	NULL
IL-13	NULL
promoter	NULL
activ-the	NULL
human	NULL
IL-13	NULL
cDNA	NULL
``	NULL
and	NULL
gene	NULL
'	NULL
represent	NULL
polymor-	NULL
ity	NULL
in	NULL
T-lineage	NULL
cells	NULL
.	NULL

RNA	NULL
blot	NULL
analysis	NULL
of	NULL
murine	NULL
T-cell	NULL
phisms	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Our	NULL
sequence	NULL
was	NULL
deter-	NULL
clones	NULL
showed	NULL
that	NULL
the	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
tend	NULL
to	NULL
be	NULL
mined	NULL
independently	NULL
for	NULL
both	NULL
strands	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
is	NULL
un-	NULL
coordinately	NULL
expressed®	NULL
``	NULL
and	NULL
suggested	NULL
that	NULL
their	NULL
transcrip-likely	NULL
to	NULL
contain	NULL
sequencing	NULL
errors	NULL
.	NULL

tion	NULL
might	NULL
be	NULL
regulated	NULL
by	NULL
common	NULL
or	NULL
similar	NULL
mechanisms	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3320	NULL
Previous	NULL
work	NULL
by	NULL
others	NULL
has	NULL
identified	NULL
a	NULL
purine-rich	NULL
se-quence	NULL
,	NULL
termed	NULL
the	NULL
P	NULL
element	NULL
,	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flank	NULL
region	NULL
of	NULL
the	NULL
murine	NULL
and	NULL
human	NULL
IL-4	NULL
genes	NULL
that	NULL
is	NULL
critical	NULL
for	NULL
their	NULL
transcription	NULL
.	NULL
``	NULL

``	NULL
*	NULL
P	NULL
elements	NULL
bind	NULL
proteins	NULL
of	NULL
the	NULL
NF-AT	NULL
transcription	NULL
factor	NULL
family	NULL
in	NULL
vitro	NULL
.	NULL
``	NULL

An	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
IL-13	NULL
gene	NULL
's	NULL
5	NULL
flank	NULL
region	NULL
showed	NULL
a	NULL
purine-rich	NULL
sequence	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
the	NULL
human	NULL
IL-4	NULL
P	NULL
element	NULL
,	NULL
PI	NULL
(	NULL
see	NULL
legend	NULL
to	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
functional	NULL
importance	NULL
of	NULL
this	NULL
putative	NULL
P	NULL
element	NULL
,	NULL
we	NULL
first	NULL
established	NULL
that	NULL
a	NULL
segment	NULL
of	NULL
the	NULL
IL-13	NULL
5	NULL
'	NULL
flank	NULL
region	NULL
,	NULL
from	NULL
-940	NULL
to	NULL
+48	NULL
,	NULL
was	NULL
sufficient	NULL
to	NULL
confer	NULL
transcription	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
using	NULL
the	NULL
construct	NULL
pIL-13//uc	NULL
.	NULL

We	NULL
found	NULL
that	NULL
Jurkat	NULL
thymoma	NULL
cells	NULL
constitutively	NULL
expressed	NULL
low	NULL
amounts	NULL
of	NULL
IL-13	NULL
transcripts	NULL
that	NULL
increased	NULL
approximately	NULL
5-	NULL
to	NULL
10-fold	NULL
after	NULL
stimulation	NULL
with	NULL
Con	NULL
A	NULL
and	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
used	NULL
this	NULL
cell	NULL
line	NULL
to	NULL
test	NULL
the	NULL
activity	NULL
of	NULL
IL-13	NULL
promoter	NULL
constructs	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
.	NULL

Promoter	NULL
activity	NULL
of	NULL
pIL-13/luc	NULL
in	NULL
unstimulated	NULL
Jurkat	NULL
cells	NULL
was	NULL
similar	NULL
to	NULL
the	NULL
background	NULL
levels	NULL
of	NULL
those	NULL
observed	NULL
with	NULL
a	NULL
promoterless	NULL
luciferase	NULL
plasmid	NULL
,	NULL
pGL-2	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

After	NULL
activation	NULL
with	NULL
Con	NULL
A	NULL
and	NULL
PMA	NULL
,	NULL
IL-13	NULL
promoter	NULL
activity	NULL
increased	NULL
approximately	NULL
100-	NULL
to	NULL
300-fold	NULL
above	NULL
the	NULL
levels	NULL
observed	NULL
in	NULL
unstimulated	NULL
cells	NULL
.	NULL

Under	NULL
these	NULL
conditions	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
CMV	NULL
immediate	NULL
early	NULL
gene	NULL
promoter	NULL
,	NULL
a	NULL
strong	NULL
and	NULL
constitutively	NULL
active	NULL
promoter	NULL
,	NULL
increased	NULL
only	NULL
about	NULL
5-fold	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
the	NULL
marked	NULL
increase	NULL
in	NULL
IL-13	NULL
promoter	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
was	NULL
not	NULL
merely	NULL
because	NULL
of	NULL
cell	NULL
activation	NULL
increasing	NULL
the	NULL
proportion	NULL
of	NULL
cells	NULL
containing	NULL
reporter	NULL
plasmids	NULL
at	NULL
the	NULL
time	NULL
of	NULL
harvest	NULL
.	NULL

IL-13	NULL
expression	NULL
by	NULL
T	NULL
cells	NULL
is	NULL
inhibited	NULL
by	NULL
CsA	NULL
,	NULL
``	NULL
and	NULL
a	NULL
variety	NULL
of	NULL
evidence	NULL
suggests	NULL
that	NULL
NF-AT	NULL
transcriptional	NULL
activator	NULL
proteins	NULL
are	NULL
major	NULL
targets	NULL
for	NULL
the	NULL
inhibition	NULL
of	NULL
cytokine	NULL
gene	NULL
transcription	NULL
by	NULL
CsA	NULL
.	NULL
``	NULL

Treatment	NULL
of	NULL
Jurkat	NULL
cells	NULL
with	NULL
CsA	NULL
reduced	NULL
the	NULL
increase	NULL
in	NULL
reporter	NULL
gene	NULL
activity	NULL
of	NULL
pIL-13/luc	NULL
after	NULL
Con	NULL
A	NULL
and	NULL
PMA	NULL
treatment	NULL
by	NULL
approximately	NULL
80	NULL
%	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

A	NULL
construct	NULL
containing	NULL
a	NULL
5-bp	NULL
substitution	NULL
mutation	NULL
of	NULL
the	NULL
IL-13	NULL
promoter	NULL
P	NULL
element	NULL
(	NULL
pIL-13mut/	NULL
luc	NULL
)	NULL
also	NULL
reduced	NULL
promoter	NULL
activity	NULL
in	NULL
stimulated	NULL
Jurkat	NULL
T	NULL
cells	NULL
by	NULL
approximately	NULL
80	NULL
%	NULL
.	NULL

This	NULL
construct	NULL
was	NULL
mutated	NULL
in	NULL
the	NULL
GGAA	NULL
residues	NULL
that	NULL
others	NULL
have	NULL
shown	NULL
to	NULL
be	NULL
critical	NULL
for	NULL
transcriptional	NULL
activation	NULL
by	NULL
IL-4	NULL
P	NULL
elements	NULL
and	NULL
for	NULL
binding	NULL
of	NULL
NF-AT	NULL
proteins	NULL
.	NULL
``	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
P	NULL
element	NULL
is	NULL
essential	NULL
for	NULL
transcription	NULL
of	NULL
the	NULL
IL-13	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
,	NULL
and	NULL
that	NULL
the	NULL
CsA-sensitive	NULL
NF-AT	NULL
family	NULL
of	NULL
proteins	NULL
are	NULL
likely	NULL
candidates	NULL
for	NULL
mediating	NULL
transcriptional	NULL
activation	NULL
via	NULL
this	NULL
element	NULL
.	NULL

CsA	NULL
treatment	NULL
of	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
transfected	NULL
with	NULL
pIL-13mut/luc	NULL
reduced	NULL
residual	NULL
promoter	NULL
activity	NULL
by	NULL
approximately	NULL
50	NULL
%	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
obtained	NULL
with	NULL
stimulated	NULL
Jurkat	NULL
cells	NULL
and	NULL
pIL-13mut//uc	NULL
without	NULL
CsA	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
portion	NULL
of	NULL
IL-13	NULL
promoter	NULL
activity	NULL
may	NULL
be	NULL
mediated	NULL
by	NULL
CsA-resistant	NULL
transcription	NULL
factors	NULL
.	NULL

The	NULL
IL-13	NULL
P	NULL
element	NULL
binds	NULL
the	NULL
transcriptional	NULL
activator	NULL
protein	NULL
NF-ATp	NULL
.	NULL

-	NULL
Using	NULL
EMSA	NULL
,	NULL
we	NULL
compared	NULL
oligonucleotides	NULL
containing	NULL
either	NULL
the	NULL
putative	NULL
IL-13	NULL
P	NULL
element	NULL
or	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
element	NULL
for	NULL
their	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
contained	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Adult	NULL
human	NULL
CD4	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
previously	NULL
been	NULL
primed	NULL
in	NULL
vitro	NULL
,	NULL
a	NULL
cell	NULL
population	NULL
that	NULL
expresses	NULL
high	NULL
levels	NULL
of	NULL
IL-4	NULL
``	NULL
and	NULL
IL-13	NULL
transcripts	NULL
DOLGANOV	NULL
ET	NULL
AL	NULL
1000	NULL
[	NULL
_	NULL
]	NULL
Unstimulated	NULL
cke	NULL
700	NULL
|-	NULL
[	NULL
]	NULL
Stimulated	NULL
K	NULL
Stimulated	NULL
+	NULL
CsA	NULL
400	NULL
|-é.\	NULL
&	NULL
100	NULL
|-	NULL
[	NULL
]	NULL
X0	NULL
i	NULL
he	NULL
2	NULL
16	NULL
}	NULL
~	NULL
C	NULL
aml	NULL
|_	NULL
S	NULL
J	NULL
12—	NULL
<	NULL
--	NULL
|	NULL
o	NULL
2	NULL
s	NULL
}	NULL
<	NULL
C	NULL
4—	NULL
0	NULL
CE	NULL
nee	NULL
Ip	NULL
-S	NULL
S	NULL
S	NULL
S	NULL
25	NULL
\	NULL
a	NULL
-	NULL
3	NULL
5	NULL
®	NULL
6	NULL
ma	NULL
-	NULL
>	NULL
sa	NULL
-	NULL
3	NULL
&	NULL
5	NULL
es	NULL
fax	NULL
3	NULL
axl	NULL
S	NULL
-Y	NULL
CL	NULL
Fal	NULL
Fig	NULL
3	NULL
.	NULL

A	NULL
P	NULL
element	NULL
contributes	NULL
to	NULL
human	NULL
IL-13	NULL
promoter	NULL
activity	NULL
in	NULL
activated	NULL
T-lineage	NULL
cells	NULL
.	NULL

Luciferase	NULL
reporter	NULL
gene	NULL
activity	NULL
in	NULL
Jurkat	NULL
thymoma	NULL
cells	NULL
transfected	NULL
with	NULL
pGL-2	NULL
,	NULL
a	NULL
promoterless	NULL
luciferase	NULL
plasmid	NULL
(	NULL
negative	NULL
control	NULL
)	NULL
;	NULL
pIL-13//uc	NULL
(	NULL
wild-type	NULL
IL-13	NULL
promoter	NULL
)	NULL
;	NULL
pIL-13mut/luc	NULL
(	NULL
IL-13	NULL
promoter	NULL
in	NULL
which	NULL
the	NULL
P	NULL
element	NULL
has	NULL
been	NULL
mutated	NULL
by	NULL
a	NULL
5-bp	NULL
substitution	NULL
)	NULL
;	NULL
or	NULL
pCMV/luc	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
in	NULL
the	NULL
absence	NULL
and	NULL
presence	NULL
of	NULL
CsA	NULL
.	NULL

For	NULL
each	NULL
transfection	NULL
,	NULL
lysates	NULL
were	NULL
analyzed	NULL
in	NULL
duplicate	NULL
for	NULL
luciferase	NULL
activity	NULL
.	NULL

The	NULL
mean	NULL
value	NULL
of	NULL
activity	NULL
+	NULL
SEM	NULL
is	NULL
shown	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
four	NULL
independent	NULL
transfection	NULL
experiments	NULL
.	NULL

(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
nuclear	NULL
protein	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4A	NULL
,	NULL
and	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
work	NULL
by	NULL
others	NULL
,	NULL
``	NULL
a	NULL
radiolabeled	NULL
probe	NULL
for	NULL
the	NULL
human	NULL
IL-4	NULL
gene	NULL
P	NULL
element	NULL
,	NULL
P1	NULL
,	NULL
formed	NULL
a	NULL
complex	NULL
with	NULL
nuclear	NULL
protein	NULL
purified	NULL
from	NULL
this	NULL
CD4	NULL
T-cell	NULL
population	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
specific	NULL
in	NULL
that	NULL
it	NULL
was	NULL
effectively	NULL
competed	NULL
with	NULL
an	NULL
unlabeled	NULL
IL-4	NULL
promoter	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
an	NULL
IL-4	NULL
P1	NULL
mutant	NULL
oligonucleotide	NULL
.	NULL

The	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
P-ele-ment-like	NULL
sequence	NULL
from	NULL
the	NULL
human	NULL
IL-13	NULL
promoter	NULL
effectively	NULL
competed	NULL
with	NULL
the	NULL
human	NULL
IL-4	NULL
PI	NULL
probe	NULL
for	NULL
specific	NULL
protein	NULL
binding	NULL
(	NULL
Fig	NULL
4A	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

This	NULL
competition	NULL
was	NULL
specific	NULL
in	NULL
that	NULL
the	NULL
mutation	NULL
of	NULL
two	NULL
adjacent	NULL
residues	NULL
in	NULL
the	NULL
IL-13	NULL
oligonucleotide	NULL
ablated	NULL
this	NULL
competition	NULL
(	NULL
Fig	NULL
4A	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

When	NULL
the	NULL
human	NULL
IL-13	NULL
promoter	NULL
oligonucleotide	NULL
,	NULL
itself	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
,	NULL
a	NULL
complex	NULL
was	NULL
formed	NULL
with	NULL
mobility	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
human	NULL
IL-4	NULL
probe	NULL
(	NULL
Fig	NULL
4B	NULL
,	NULL
lane	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

COEXPRESSION	NULL
OF	NULL
IL-4	NULL
AND	NULL
IL-13	NULL
A	NULL
.	NULL

Human	NULL
IL-4	NULL
Probe	NULL
B	NULL
.	NULL

Human	NULL
IL-13	NULL
Probe	NULL
&	NULL
s	NULL
0g	NULL
oll	NULL
G	NULL
$	NULL
Competitor	NULL
:	NULL
-	NULL
&	NULL
=	NULL
43	NULL
-	NULL
&	NULL
§	NULL
1	NULL
%	NULL
-	NULL
_	NULL
=	NULL
Anti-NFATp	NULL
:	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
Loc	NULL
4	NULL
-	NULL
-	NULL
4	NULL
og	NULL
Peptide	NULL
:	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
meine	NULL
ses	NULL
m	NULL
is	NULL
:	NULL
$	NULL
9	NULL
Uff	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
Gel-shift	NULL
assays	NULL
for	NULL
nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
and	NULL
the	NULL
putative	NULL
human	NULL
IL-13	NULL
P	NULL
element	NULL
oligonucleotides	NULL
.	NULL

Nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
in	NULL
vitro-primed	NULL
adult	NULL
T	NULL
cells	NULL
activated	NULL
for	NULL
2	NULL
hours	NULL
with	NULL
Con	NULL
A	NULL
and	NULL
PMA	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
unlabeled	NULL
oligonucleotides	NULL
were	NULL
added	NULL
at	NULL
a	NULL
50-fold	NULL
molar	NULL
excess	NULL
relative	NULL
to	NULL
the	NULL
probe	NULL
in	NULL
competition	NULL
reactions	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Complexes	NULL
formed	NULL
with	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
probe	NULL
,	NULL
ATTGGAAATTTTCGTTA	NULL
(	NULL
noncoding	NULL
strand	NULL
is	NULL
shown	NULL
)	NULL
.	NULL

Unlabeled	NULL
oligonucleotides	NULL
added	NULL
included	NULL
none	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
self	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
a	NULL
mutant	NULL
hIL-4	NULL
P1	NULL
oligonucleotide	NULL
,	NULL
ATTATAAATTTTCGTTA	NULL
(	NULL
lanes	NULL
3	NULL
)	NULL
,	NULL
the	NULL
human	NULL
IL-13	NULL
gene	NULL
P	NULL
element-like	NULL
site	NULL
,	NULL
TGTGGAAAATCCAGTG	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
and	NULL
a	NULL
mutant	NULL
hIL-13	NULL
oligonucleotide	NULL
,	NULL
TGTGGTCAATCCAGTG	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Complexes	NULL
formed	NULL
with	NULL
a	NULL
human	NULL
IL-13	NULL
P	NULL
element-like	NULL
probe	NULL
(	NULL
TGTGGAAAATCCAGTG	NULL
)	NULL
.	NULL

Unlabeled	NULL
oligonucleotides	NULL
added	NULL
included	NULL
none	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
6-8	NULL
)	NULL
,	NULL
self	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
a	NULL
mutant	NULL
IL-13	NULL
P1	NULL
oligonucleotide	NULL
,	NULL
TGTGGTCAATCCAGTG	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
the	NULL
hIL-4	NULL
P1	NULL
site	NULL
,	NULL
ATTGGAAATTTTCGTTA	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
a	NULL
mutant	NULL
hIL-4	NULL
oligonucleotide	NULL
,	NULL
ATTATAAATTTTCGTTA	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Specific	NULL
antiserum	NULL
to	NULL
NF-ATp	NULL
was	NULL
added	NULL
to	NULL
lanes	NULL
6-8	NULL
,	NULL
alone	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
NF-ATp	NULL
peptide	NULL
to	NULL
which	NULL
the	NULL
antiserum	NULL
was	NULL
raised	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
or	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
irrelevant	NULL
peptide	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

1	NULL
)	NULL
.	NULL

This	NULL
complex	NULL
was	NULL
specific	NULL
in	NULL
that	NULL
it	NULL
was	NULL
efficiently	NULL
competed	NULL
by	NULL
unlabeled	NULL
IL-13	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
an	NULL
IL-13	NULL
mutant	NULL
oligonucleotide	NULL
.	NULL

The	NULL
human	NULL
IL-4	NULL
P1	NULL
element	NULL
oligonucleotide	NULL
was	NULL
also	NULL
an	NULL
effective	NULL
competitor	NULL
for	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
IL-13	NULL
probe	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
mutant	NULL
IL-4	NULL
P1	NULL
oligonucleotide	NULL
that	NULL
was	NULL
ineffective	NULL
in	NULL
blocking	NULL
nuclear	NULL
protein	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
IL-4	NULL
P1	NULL
element	NULL
(	NULL
Fig	NULL
4B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
was	NULL
also	NULL
ineffective	NULL
in	NULL
competition	NULL
with	NULL
the	NULL
IL-13	NULL
probe	NULL
.	NULL

The	NULL
majority	NULL
of	NULL
the	NULL
IL-13	NULL
oligonucleotide-protein	NULL
complex	NULL
was	NULL
efficiently	NULL
supershifted	NULL
by	NULL
NF-ATp	NULL
antiserum	NULL
(	NULL
Fig	NULL
4B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
as	NULL
was	NULL
the	NULL
complex	NULL
formed	NULL
with	NULL
the	NULL
human	NULL
IL-4	NULL
P1	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Inclusion	NULL
of	NULL
the	NULL
specific	NULL
NF-ATp	NULL
peptide	NULL
to	NULL
which	NULL
the	NULL
antiserum	NULL
was	NULL
raised	NULL
prevented	NULL
this	NULL
supershift	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
whereas	NULL
inclusion	NULL
of	NULL
an	NULL
equal	NULL
amount	NULL
of	NULL
irrelevant	NULL
peptide	NULL
did	NULL
not	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
IL-4	NULL
P1	NULL
and	NULL
IL-13	NULL
P	NULL
element	NULL
oligonucleotides	NULL
had	NULL
similar	NULL
or	NULL
identical	NULL
binding	NULL
specificity	NULL
for	NULL
nuclear	NULL
proteins	NULL
from	NULL
activated	NULL
CD4	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
primed	NULL
in	NULL
vitro	NULL
.	NULL

We	NULL
also	NULL
3321	NULL
observed	NULL
this	NULL
NF-ATp-containing	NULL
complex	NULL
with	NULL
the	NULL
IL-13	NULL
or	NULL
IL-4	NULL
P	NULL
element	NULL
oligonucleotides	NULL
when	NULL
freshly-isolated	NULL
adult	NULL
CD4	NULL
T	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
polyclonally	NULL
activated	NULL
for	NULL
2	NULL
hours	NULL
were	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
nuclear	NULL
protein	NULL
.	NULL

However	NULL
,	NULL
the	NULL
amount	NULL
of	NULL
complex	NULL
under	NULL
these	NULL
conditions	NULL
was	NULL
only	NULL
about	NULL
one	NULL
tenth	NULL
that	NULL
observed	NULL
when	NULL
primed	NULL
CD4	NULL
T-cell	NULL
protein	NULL
extracts	NULL
were	NULL
used	NULL
with	NULL
either	NULL
the	NULL
IL-4	NULL
``	NULL
or	NULL
the	NULL
IL-13	NULL
P	NULL
element	NULL
probes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
show	NULL
a	NULL
striking	NULL
correlation	NULL
between	NULL
the	NULL
abundance	NULL
of	NULL
nuclear	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
human	NULL
IL-13	NULL
and	NULL
human	NULL
IL-4	NULL
P	NULL
elements	NULL
and	NULL
the	NULL
capacity	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
express	NULL
the	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
major	NULL
component	NULL
of	NULL
nuclear	NULL
protein	NULL
binding	NULL
to	NULL
these	NULL
P	NULL
elements	NULL
in	NULL
activated	NULL
adult	NULL
CD4	NULL
T	NULL
cells	NULL
was	NULL
NF-ATp	NULL
.	NULL

IL-13	NULL
mRNA	NULL
expression	NULL
by	NULL
human	NULL
T-cell	NULL
populations	NULL
.	NULL

To	NULL
gain	NULL
insight	NULL
into	NULL
the	NULL
cellular	NULL
mechanisms	NULL
regulating	NULL
IL-13	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
compared	NULL
IL-13	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
normal	NULL
human	NULL
T-cell	NULL
populations	NULL
after	NULL
polyclonal	NULL
activation	NULL
.	NULL

We	NULL
first	NULL
examined	NULL
the	NULL
kinetics	NULL
of	NULL
IL-13	NULL
transcript	NULL
expression	NULL
by	NULL
circulating	NULL
freshly	NULL
isolated	NULL
adult	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
5	NULL
,	NULL
lanes	NULL
1-4	NULL
)	NULL
.	NULL

IL-13	NULL
transcripts	NULL
were	NULL
undetectable	NULL
in	NULL
unstimulated	NULL
cells	NULL
but	NULL
were	NULL
observed	NULL
after	NULL
activation	NULL
with	NULL
Con	NULL
A	NULL
and	NULL
PMA	NULL
,	NULL
with	NULL
peak	NULL
levels	NULL
achieved	NULL
at	NULL
approximately	NULL
6	NULL
hours	NULL
of	NULL
incubation	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
IL-2	NULL
and	NULL
IL-4	NULL
mRNA	NULL
accumulation	NULL
after	NULL
activation	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
IL-13	NULL
transcripts	NULL
.	NULL

Levels	NULL
of	NULL
transcripts	NULL
for	NULL
all	NULL
three	NULL
cytokines	NULL
were	NULL
typically	NULL
low	NULL
to	NULL
Cell	NULL
type	NULL
:	NULL
Con	NULL
A	NULL
+	NULL
PMA	NULL
(	NULL
hrs	NULL
)	NULL
:	NULL
O0	NULL
_	NULL
6	NULL
1	NULL
=	NULL
co4*	NULL
co4sRA®	NULL
Probe	NULL
:	NULL
IL-13	NULL
IL-4	NULL
IL-2	NULL
EF	NULL
Fig	NULL
5	NULL
.	NULL

Total	NULL
RNA	NULL
hybridized	NULL
with	NULL
IL-13	NULL
,	NULL
IL-4	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
EF-1	NULL
«	NULL
probes	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
5	NULL
pg	NULL
)	NULL
was	NULL
loaded	NULL
into	NULL
each	NULL
lane	NULL
.	NULL

RNA	NULL
from	NULL
adult	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
,	NULL
either	NULL
unstimulated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
activated	NULL
with	NULL
Con	NULL
A	NULL
and	NULL
PMA	NULL
for	NULL
6	NULL
hours	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
12	NULL
hours	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
and	NULL
24	NULL
hours	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

RNA	NULL
from	NULL
unfractionated	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
CD45RA~	NULL
adult	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
activated	NULL
with	NULL
Con	NULL
A	NULL
and	NULL
PMA	NULL
for	NULL
6	NULL
hours	NULL
.	NULL

The	NULL
blot	NULL
shown	NULL
is	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3322	NULL
undetectable	NULL
at	NULL
24	NULL
hours	NULL
of	NULL
incubation	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
transcripts	NULL
for	NULL
EF-la	NULL
,	NULL
an	NULL
abundant	NULL
'*housekeeping'*	NULL
gene	NULL
product	NULL
involved	NULL
in	NULL
protein	NULL
translation	NULL
,	NULL
``	NULL
was	NULL
similar	NULL
in	NULL
all	NULL
lanes	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
differences	NULL
in	NULL
cytokine	NULL
mRNA	NULL
levels	NULL
observed	NULL
at	NULL
different	NULL
time	NULL
points	NULL
were	NULL
not	NULL
caused	NULL
by	NULL
differences	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
total	NULL
RNA	NULL
loaded	NULL
per	NULL
lane	NULL
.	NULL

Similar	NULL
kinetics	NULL
of	NULL
cytokine	NULL
mRNA	NULL
accumulation	NULL
were	NULL
also	NULL
observed	NULL
for	NULL
the	NULL
IL-13	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-2	NULL
genes	NULL
when	NULL
adult	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
ionomycin	NULL
and	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Circulating	NULL
CD4	NULL
T	NULL
cells	NULL
from	NULL
healthy	NULL
adults	NULL
are	NULL
comprised	NULL
of	NULL
two	NULL
mutually	NULL
exclusive	NULL
subsets	NULL
identified	NULL
by	NULL
their	NULL
reciprocal	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
CD4SRA	NULL
and	NULL
CD4SRO	NULL
isoforms	NULL
of	NULL
the	NULL
CD45	NULL
protein	NULL
tyrosine	NULL
phosphatase	NULL
molecule	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
To	NULL
determine	NULL
if	NULL
IL-13	NULL
was	NULL
differentially	NULL
expressed	NULL
by	NULL
CD4	NULL
T	NULL
cells	NULL
based	NULL
on	NULL
their	NULL
surface	NULL
expression	NULL
of	NULL
CD45	NULL
isoforms	NULL
,	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
by	NULL
the	NULL
CD4S5RA~	NULL
(	NULL
CD4S5RO*	NULL
)	NULL
and	NULL
unfractionated	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
compared	NULL
after	NULL
their	NULL
activation	NULL
in	NULL
vitro	NULL
.	NULL

CD4S5RA~CD4	NULL
T	NULL
cells	NULL
were	NULL
highly	NULL
enriched	NULL
in	NULL
IL-13	NULL
mRNA	NULL
as	NULL
compared	NULL
with	NULL
unfractionated	NULL
CD4	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
5	NULL
,	NULL
lane	NULL
5	NULL
v	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
results	NULL
,	NULL
``	NULL
``	NULL
an	NULL
enrichment	NULL
for	NULL
IL-4	NULL
mRNA	NULL
expression	NULL
by	NULL
CD45RA~CD4	NULL
T	NULL
cells	NULL
was	NULL
also	NULL
ob-served	NULL
.	NULL

Depending	NULL
on	NULL
the	NULL
donor	NULL
used	NULL
,	NULL
IL-2	NULL
mRNA	NULL
levels	NULL
in	NULL
CD45SRA	NULL
~CD4	NULL
T	NULL
cells	NULL
ranged	NULL
from	NULL
being	NULL
substantially	NULL
lower	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
or	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
unfractionated	NULL
CD4	NULL
T	NULL
cells	NULL
``	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
enrichment	NULL
for	NULL
IL-4	NULL
and	NULL
IL-13	NULL
mRNA	NULL
expression	NULL
by	NULL
CD45RA~CD4	NULL
T	NULL
cells	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
by	NULL
unfractionated	NULL
CD4	NULL
T	NULL
cells	NULL
was	NULL
consistent	NULL
in	NULL
all	NULL
four	NULL
blood	NULL
donors	NULL
we	NULL
examined	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
variety	NULL
of	NULL
evidence	NULL
suggests	NULL
that	NULL
circulating	NULL
CD4SRO*	NULL
T	NULL
cells	NULL
represent	NULL
a	NULL
population	NULL
that	NULL
has	NULL
previously	NULL
been	NULL
activated	NULL
or	NULL
'	NULL
``	NULL
``	NULL
primed	NULL
``	NULL
'	NULL
in	NULL
vivo	NULL
by	NULL
antigen	NULL
.	NULL

``	NULL
``	NULL
``	NULL
*	NULL
``	NULL
°	NULL
Taken	NULL
together	NULL
with	NULL
the	NULL
results	NULL
above	NULL
,	NULL
this	NULL
suggests	NULL
that	NULL
priming	NULL
of	NULL
T	NULL
cells	NULL
preferentially	NULL
upregulates	NULL
IL-13	NULL
but	NULL
not	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

Two	NULL
predictions	NULL
of	NULL
this	NULL
model	NULL
are	NULL
that	NULL
(	NULL
1	NULL
)	NULL
IL-13	NULL
mRNA	NULL
expression	NULL
should	NULL
be	NULL
low	NULL
to	NULL
undetectable	NULL
in	NULL
T-cell	NULL
populations	NULL
that	NULL
have	NULL
had	NULL
limited	NULL
exposure	NULL
to	NULL
antigens	NULL
,	NULL
such	NULL
as	NULL
neonatal	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
(	NULL
2	NULL
)	NULL
priming	NULL
of	NULL
these	NULL
antigenically	NULL
naive	NULL
populations	NULL
by	NULL
repetitive	NULL
activation	NULL
in	NULL
vitro	NULL
should	NULL
upregu-late	NULL
expression	NULL
of	NULL
the	NULL
IL-13	NULL
gene	NULL
but	NULL
not	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

To	NULL
test	NULL
these	NULL
predictions	NULL
,	NULL
freshly-isolated	NULL
neonatal	NULL
T	NULL
cells	NULL
,	NULL
adult	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
several	NULL
clones	NULL
derived	NULL
from	NULL
neonatal	NULL
CD4	NULL
T	NULL
cells	NULL
or	NULL
adult	NULL
CD4	NULL
T	NULL
cells	NULL
were	NULL
compared	NULL
for	NULL
their	NULL
expression	NULL
of	NULL
IL-13	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-2	NULL
mRNA	NULL
after	NULL
activation	NULL
in	NULL
vitro	NULL
.	NULL

IL-13	NULL
was	NULL
undetectable	NULL
in	NULL
freshly	NULL
isolated	NULL
neonatal	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
adult	NULL
T	NULL
cells	NULL
routinely	NULL
contained	NULL
substantial	NULL
levels	NULL
of	NULL
IL-13	NULL
transcripts	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

In	NULL
agreement	NULL
with	NULL
previous	NULL
published	NULL
results	NULL
,	NULL
``	NULL
``	NULL
the	NULL
pattern	NULL
of	NULL
IL-4	NULL
mRNA	NULL
expression	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
was	NULL
,	NULL
similar	NULL
to	NULL
IL-13	NULL
mRNA	NULL
expression	NULL
,	NULL
low	NULL
to	NULL
undetectable	NULL
,	NULL
whereas	NULL
,	NULL
in	NULL
contrast	NULL
,	NULL
the	NULL
level	NULL
of	NULL
IL-2	NULL
transcripts	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
adult	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
selective	NULL
deficits	NULL
in	NULL
cytokine	NULL
expression	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
by	NULL
adult	NULL
T	NULL
cells	NULL
were	NULL
observed	NULL
after	NULL
activation	NULL
with	NULL
either	NULL
Con	NULL
A	NULL
and	NULL
PMA	NULL
or	NULL
with	NULL
ionomycin	NULL
and	NULL
PMA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Unlike	NULL
freshly	NULL
isolated	NULL
cells	NULL
,	NULL
neonatal	NULL
CD4	NULL
T	NULL
cells	NULL
propagated	NULL
in	NULL
vitro	NULL
as	NULL
clones	NULL
expressed	NULL
high	NULL
levels	NULL
of	NULL
IL-13	NULL
and	NULL
IL-4	NULL
transcripts	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-2	NULL
gene	NULL
DOLGANOV	NULL
ET	NULL
AL	NULL
Adult	NULL
NB	NULL
NB	NULL
Adult	NULL
T	NULL
T	NULL
CD4	NULL
Clones	NULL
CD4	NULL
Clones	NULL
ConA	NULL
+	NULL
PMA	NULL
:	NULL
'-	NULL
+/+	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
4+	NULL
4+	NULL
+	NULL
IL-13	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
1011	NULL
Fig	NULL
6	NULL
.	NULL

-	NULL
RNA	NULL
from	NULL
adult	NULL
T	NULL
cells	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
neonatal	NULL
T	NULL
cells	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
four	NULL
individual	NULL
neonatal	NULL
CD4	NULL
T-cell	NULL
clones	NULL
(	NULL
NB-1	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
;	NULL
NB-2	NULL
,	NULL
lane	NULL
6	NULL
;	NULL
NB-3	NULL
,	NULL
lane	NULL
7	NULL
;	NULL
and	NULL
NB-4	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
and	NULL
three	NULL
individual	NULL
adult	NULL
CD4	NULL
T-cell	NULL
clones	NULL
(	NULL
AD-1	NULL
,	NULL
lane	NULL
9	NULL
;	NULL
AD-2	NULL
,	NULL
lane	NULL
10	NULL
;	NULL
and	NULL
AD-3	NULL
,	NULL
lane	NULL
11	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
unstimulated	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
4	NULL
)	NULL
or	NULL
activated	NULL
with	NULL
Con	NULL
A	NULL
and	NULL
PMA	NULL
for	NULL
6	NULL
hours	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5-11	NULL
)	NULL
.	NULL

The	NULL
blot	NULL
shown	NULL
is	NULL
representative	NULL
of	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

expression	NULL
by	NULL
individual	NULL
clones	NULL
was	NULL
either	NULL
similar	NULL
,	NULL
or	NULL
only	NULL
modestly	NULL
increased	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
that	NULL
found	NULL
in	NULL
freshly-isolated	NULL
cells	NULL
.	NULL

These	NULL
neonatal	NULL
clones	NULL
were	NULL
of	NULL
the	NULL
Th	NULL
,	NULL
type	NULL
in	NULL
that	NULL
they	NULL
also	NULL
expressed	NULL
significant	NULL
amounts	NULL
of	NULL
IFN-y	NULL
mRNA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
marked	NULL
increases	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
,	NULL
but	NULL
not	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
,	NULL
in	NULL
neonatal	NULL
or	NULL
adult	NULL
CD4	NULL
T	NULL
cells	NULL
that	NULL
were	NULL
primed	NULL
in	NULL
vitro	NULL
in	NULL
bulk	NULL
for	NULL
10	NULL
to	NULL
14	NULL
days	NULL
and	NULL
were	NULL
then	NULL
restimulated	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

DISCUSSION	NULL
We	NULL
and	NULL
others	NULL
have	NULL
shown	NULL
physical	NULL
linkage	NULL
for	NULL
at	NULL
least	NULL
five	NULL
cytokine	NULL
genes	NULL
in	NULL
5q23-31	NULL
,	NULL
``	NULL
°	NULL
``	NULL
``	NULL
including	NULL
IL-13	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
IL-3	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
IL-9	NULL
.	NULL

This	NULL
close	NULL
physical	NULL
linkage	NULL
is	NULL
also	NULL
confirmed	NULL
by	NULL
synteny	NULL
studies	NULL
in	NULL
mice	NULL
that	NULL
indicate	NULL
that	NULL
these	NULL
cytokines	NULL
map	NULL
to	NULL
mouse	NULL
chromosome	NULL
11.2	NULL
A	NULL
comparison	NULL
of	NULL
the	NULL
different	NULL
chromosome	NULL
5	NULL
cytokine	NULL
genes	NULL
with	NULL
each	NULL
other	NULL
shows	NULL
similar	NULL
exon	NULL
sizes	NULL
and	NULL
exon-intron	NULL
struc-ture	NULL
,	NULL
some	NULL
limited	NULL
DNA	NULL
sequence	NULL
homology	NULL
in	NULL
their	NULL
5	NULL
'	NULL
flank	NULL
regulatory	NULL
regions	NULL
,	NULL
and	NULL
some	NULL
limited	NULL
amino	NULL
acid	NULL
homology	NULL
in	NULL
their	NULL
N-	NULL
and	NULL
C-terminal	NULL
regions	NULL
.	NULL
``	NULL

However	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
of	NULL
the	NULL
IL-4	NULL
and	NULL
IL-13	NULL
genes	NULL
,	NULL
most	NULL
of	NULL
the	NULL
coding	NULL
sequences	NULL
of	NULL
this	NULL
cytokine	NULL
cluster	NULL
show	NULL
little	NULL
sequence	NULL
homology	NULL
with	NULL
one	NULL
another	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
genes	NULL
,	NULL
as	NULL
a	NULL
group	NULL
,	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
clustered	NULL
because	NULL
of	NULL
recent	NULL
gene	NULL
duplica-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

COEXPRESSION	NULL
OF	NULL
IL-4	NULL
AND	NULL
IL-13	NULL
tion	NULL
events	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
unclear	NULL
why	NULL
all	NULL
of	NULL
these	NULL
cytokine	NULL
genes	NULL
have	NULL
remained	NULL
clustered	NULL
during	NULL
evolution	NULL
,	NULL
the	NULL
contiguity	NULL
of	NULL
the	NULL
IL-3	NULL
and	NULL
GM-CSF	NULL
genes	NULL
(	NULL
10	NULL
kb	NULL
apart	NULL
in	NULL
the	NULL
human	NULL
and	NULL
14	NULL
kb	NULL
apart	NULL
in	NULL
the	NULL
mouse	NULL
)	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
their	NULL
sharing	NULL
an	NULL
enhancer	NULL
segment	NULL
located	NULL
between	NULL
the	NULL
two	NULL
genes	NULL
.	NULL

``	NULL
*	NULL
``	NULL
°	NULL
The	NULL
fact	NULL
that	NULL
the	NULL
human	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
are	NULL
located	NULL
a	NULL
similar	NULL
distance	NULL
apart	NULL
(	NULL
12	NULL
kb	NULL
)	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
these	NULL
two	NULL
cytokine	NULL
genes	NULL
might	NULL
also	NULL
share	NULL
an	NULL
enhancer	NULL
element	NULL
.	NULL

The	NULL
finding	NULL
of	NULL
a	NULL
CpG	NULL
island	NULL
2	NULL
kb	NULL
upstream	NULL
from	NULL
the	NULL
human	NULL
IL-13	NULL
gene	NULL
is	NULL
unexpected	NULL
in	NULL
that	NULL
CpG	NULL
islands	NULL
have	NULL
not	NULL
been	NULL
previously	NULL
observed	NULL
in	NULL
the	NULL
regions	NULL
flanking	NULL
the	NULL
genes	NULL
that	NULL
encode	NULL
other	NULL
T-cell-derived	NULL
cytokines	NULL
,	NULL
including	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-5	NULL
,	NULL
IL-6	NULL
,	NULL
GM-CSF	NULL
,	NULL
and	NULL
IFN-y	NULL
.	NULL

CpG	NULL
islands	NULL
have	NULL
been	NULL
implicated	NULL
in	NULL
maintenance	NULL
of	NULL
an	NULL
open	NULL
chromatin	NULL
configuration	NULL
that	NULL
may	NULL
facilitate	NULL
gene	NULL
transcription	NULL
.	NULL
``	NULL

Further	NULL
studies	NULL
will	NULL
be	NULL
required	NULL
to	NULL
establish	NULL
that	NULL
the	NULL
CpG	NULL
island	NULL
proximal	NULL
to	NULL
the	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genetic	NULL
loci	NULL
influence	NULL
their	NULL
transcriptional	NULL
activation	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
contiguity	NULL
of	NULL
the	NULL
IL-4	NULL
and	NULL
IL-13	NULL
genes	NULL
that	NULL
we	NULL
have	NULL
shown	NULL
here	NULL
,	NULL
their	NULL
significant	NULL
genetic	NULL
homology	NULL
,	NULL
``	NULL
and	NULL
,	NULL
based	NULL
on	NULL
an	NULL
analysis	NULL
of	NULL
murine	NULL
CD4	NULL
T-cell	NULL
clones	NULL
,	NULL
their	NULL
tendency	NULL
to	NULL
be	NULL
coordinately	NULL
expressed*	NULL
``	NULL
suggested	NULL
that	NULL
the	NULL
promoters	NULL
of	NULL
these	NULL
cytokines	NULL
genes	NULL
might	NULL
use	NULL
similar	NULL
cis-regulatory	NULL
elements	NULL
.	NULL

Although	NULL
we	NULL
only	NULL
found	NULL
about	NULL
20	NULL
%	NULL
sequence	NULL
homology	NULL
between	NULL
the	NULL
IL-13	NULL
and	NULL
IL-4	NULL
promoter	NULL
regions	NULL
over	NULL
the	NULL
first	NULL
2	NULL
kb	NULL
5	NULL
'	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
purine-rich	NULL
sequence	NULL
in	NULL
the	NULL
IL-13	NULL
promoter	NULL
homologous	NULL
to	NULL
the	NULL
P	NULL
elements	NULL
of	NULL
the	NULL
IL-4	NULL
gene	NULL
.	NULL

Our	NULL
results	NULL
using	NULL
transiently	NULL
transfected	NULL
reporter	NULL
gene	NULL
constructs	NULL
show	NULL
that	NULL
this	NULL
element	NULL
significantly	NULL
contributes	NULL
to	NULL
IL-13	NULL
promoter	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
.	NULL

We	NULL
found	NULL
that	NULL
this	NULL
IL-13	NULL
P	NULL
element	NULL
was	NULL
similar	NULL
to	NULL
the	NULL
IL-4	NULL
promoter	NULL
P1	NULL
element	NULL
in	NULL
specifically	NULL
binding	NULL
in	NULL
vitro	NULL
the	NULL
transcription	NULL
activator	NULL
protein	NULL
,	NULL
NF-ATp	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
found	NULL
a	NULL
striking	NULL
direct	NULL
correlation	NULL
in	NULL
normal	NULL
human	NULL
T-lineage	NULL
cell	NULL
populations	NULL
between	NULL
the	NULL
amount	NULL
of	NULL
NF-ATp	NULL
in	NULL
the	NULL
nucleus	NULL
after	NULL
activation	NULL
and	NULL
the	NULL
capacity	NULL
of	NULL
T	NULL
cells	NULL
to	NULL
express	NULL
IL-4	NULL
``	NULL
and	NULL
IL-13	NULL
mRNA	NULL
(	NULL
D.	NULL
Lewis	NULL
and	NULL
S.	NULL
Bort	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

NF-AT	NULL
protein	NULL
translocation	NULL
from	NULL
the	NULL
cytoplasm	NULL
to	NULL
nucleus	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
is	NULL
inhibited	NULL
by	NULL
CsA®	NULL
.	NULL

Therefore	NULL
,	NULL
our	NULL
finding	NULL
that	NULL
IL-13	NULL
promoter	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
was	NULL
markedly	NULL
inhibited	NULL
by	NULL
CsA	NULL
supports	NULL
the	NULL
idea	NULL
that	NULL
NF-AT	NULL
proteins	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
IL-13	NULL
transcription	NULL
by	NULL
T	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

Together	NULL
,	NULL
our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
the	NULL
availability	NULL
of	NULL
NF-ATp	NULL
for	NULL
binding	NULL
to	NULL
these	NULL
two	NULL
cytokine	NULL
genes	NULL
could	NULL
be	NULL
an	NULL
important	NULL
determinant	NULL
of	NULL
the	NULL
efficiency	NULL
with	NULL
which	NULL
they	NULL
are	NULL
transcribed	NULL
.	NULL

In	NULL
a	NULL
number	NULL
of	NULL
T-cell-derived	NULL
cytokine	NULL
promoters	NULL
,	NULL
including	NULL
that	NULL
for	NULL
the	NULL
IL-4	NULL
gene	NULL
,	NULL
NF-AT-binding	NULL
P	NULL
elements	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
adjacent	NULL
AP-1	NULL
binding	NULL
sites	NULL
in	NULL
activating	NULL
transcription	NULL
.	NULL
``	NULL

Whether	NULL
this	NULL
is	NULL
true	NULL
for	NULL
the	NULL
P	NULL
element	NULL
site	NULL
of	NULL
the	NULL
IL-13	NULL
gene	NULL
that	NULL
we	NULL
have	NULL
identified	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
a	NULL
modest	NULL
portion	NULL
of	NULL
IL-13	NULL
promoter	NULL
activity	NULL
persisted	NULL
in	NULL
Jurkat	NULL
cells	NULL
treated	NULL
with	NULL
CsA	NULL
and	NULL
transfected	NULL
with	NULL
an	NULL
IL-13	NULL
promoter	NULL
construct	NULL
in	NULL
which	NULL
the	NULL
P	NULL
element	NULL
site	NULL
was	NULL
mutated	NULL
is	NULL
consistent	NULL
with	NULL
a	NULL
role	NULL
for	NULL
transcription	NULL
factors	NULL
other	NULL
than	NULL
NF-AT	NULL
proteins	NULL
in	NULL
directing	NULL
IL-13	NULL
gene	NULL
3323	NULL
transcription	NULL
.	NULL

A	NULL
number	NULL
of	NULL
other	NULL
transcription	NULL
factors	NULL
besides	NULL
NF-ATp	NULL
and	NULL
AP-1	NULL
,	NULL
including	NULL
HMG-1	NULL
,	NULL
NF-Y	NULL
,	NULL
and	NULL
octamer	NULL
proteins	NULL
,	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
bind	NULL
to	NULL
cis-elements	NULL
in	NULL
the	NULL
IL-4	NULL
5	NULL
'	NULL
flank	NULL
region**	NULL
``	NULL
'	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
are	NULL
candidates	NULL
to	NULL
regulate	NULL
IL-4	NULL
gene	NULL
transcription	NULL
.	NULL

Because	NULL
there	NULL
are	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
these	NULL
and	NULL
other	NULL
DNA	NULL
binding	NULL
proteins	NULL
in	NULL
the	NULL
human	NULL
IL-13	NULL
5	NULL
``	NULL
flank	NULL
region	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
it	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
if	NULL
these	NULL
proteins	NULL
also	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-13	NULL
gene	NULL
.	NULL

We	NULL
found	NULL
that	NULL
the	NULL
human	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
were	NULL
coordinately	NULL
expressed	NULL
by	NULL
various	NULL
human	NULL
T-cell	NULL
populations	NULL
,	NULL
both	NULL
in	NULL
bulk	NULL
and	NULL
at	NULL
the	NULL
clonal	NULL
level	NULL
,	NULL
but	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
this	NULL
is	NULL
achieved	NULL
remain	NULL
unclear	NULL
.	NULL

The	NULL
temporal	NULL
patterns	NULL
of	NULL
IL-13	NULL
,	NULL
IL-4	NULL
,	NULL
and	NULL
IL-2	NULL
mRNA	NULL
accumulation	NULL
after	NULL
T-cell	NULL
activation	NULL
were	NULL
similar	NULL
,	NULL
with	NULL
peak	NULL
levels	NULL
achieved	NULL
for	NULL
all	NULL
three	NULL
cytokine	NULL
transcripts	NULL
at	NULL
approximately	NULL
6	NULL
hours	NULL
of	NULL
incubation	NULL
.	NULL

By	NULL
24	NULL
hours	NULL
of	NULL
incubation	NULL
,	NULL
transcript	NULL
levels	NULL
for	NULL
all	NULL
three	NULL
cytokine	NULL
genes	NULL
were	NULL
very	NULL
low	NULL
to	NULL
undetect-able	NULL
.	NULL

These	NULL
results	NULL
differ	NULL
from	NULL
those	NULL
of	NULL
Zurawski	NULL
and	NULL
de	NULL
Vries	NULL
``	NULL
who	NULL
reported	NULL
that	NULL
human	NULL
T-cell	NULL
clones	NULL
activated	NULL
in	NULL
vitro	NULL
had	NULL
detectable	NULL
IL-13	NULL
mRNA	NULL
levels	NULL
for	NULL
up	NULL
to	NULL
72	NULL
hours	NULL
after	NULL
activation	NULL
,	NULL
long	NULL
after	NULL
IL-4	NULL
mRNA	NULL
had	NULL
decreased	NULL
to	NULL
undetectable	NULL
levels	NULL
.	NULL

Whether	NULL
these	NULL
differences	NULL
reflect	NULL
the	NULL
particular	NULL
T-cell	NULL
populations	NULL
studied	NULL
(	NULL
freshly	NULL
isolated	NULL
T	NULL
cells	NULL
versus	NULL
clones	NULL
)	NULL
or	NULL
the	NULL
stimulus	NULL
used	NULL
for	NULL
activation	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Based	NULL
on	NULL
studies	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
by	NULL
T	NULL
cells	NULL
,	NULL
``	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
transient	NULL
wave	NULL
of	NULL
IL-13	NULL
and	NULL
IL-4	NULL
mRNA	NULL
accumulation	NULL
that	NULL
we	NULL
observed	NULL
after	NULL
activation	NULL
in	NULL
vitro	NULL
is	NULL
cause	NULL
,	NULL
in	NULL
part	NULL
,	NULL
by	NULL
the	NULL
relatively	NULL
short	NULL
period	NULL
during	NULL
which	NULL
these	NULL
cytokine	NULL
genes	NULL
are	NULL
transcribed	NULL
(	NULL
D.	NULL
Lewis	NULL
,	NULL
unpublished	NULL
observations	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
transient	NULL
accumulation	NULL
of	NULL
IL-13	NULL
may	NULL
also	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
IL-13	NULL
transcript	NULL
,	NULL
similar	NULL
to	NULL
those	NULL
for	NULL
IL-4	NULL
``	NULL
and	NULL
IL-2	NULL
,	NULL
``	NULL
contains	NULL
AUUUA	NULL
sequences	NULL
in	NULL
the	NULL
3	NULL
'	NULL
untranslated	NULL
region	NULL
that	NULL
appear	NULL
to	NULL
decrease	NULL
mRNA	NULL
stability	NULL
.	NULL
``	NULL

The	NULL
current	NULL
study	NULL
also	NULL
shows	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
IL-13	NULL
and	NULL
IL-2	NULL
genes	NULL
in	NULL
freshly	NULL
isolated	NULL
human	NULL
T	NULL
cells	NULL
is	NULL
independently	NULL
modulated	NULL
.	NULL

Among	NULL
adult	NULL
CD4	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
CD45RA~	NULL
(	NULL
CD45RO*	NULL
)	NULL
subset	NULL
was	NULL
highly	NULL
enriched	NULL
in	NULL
the	NULL
capacity	NULL
to	NULL
express	NULL
IL-13	NULL
mRNA	NULL
and	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
results	NULL
of	NULL
earlier	NULL
results	NULL
,	NULL
``	NULL
``	NULL
IL-4	NULL
mRNA	NULL
,	NULL
whereas	NULL
the	NULL
expression	NULL
of	NULL
IL-2	NULL
transcripts	NULL
was	NULL
not	NULL
enhanced	NULL
.	NULL

The	NULL
CD4SRA*	NULL
and	NULL
CD45RO+*	NULL
subsets	NULL
comprise	NULL
approximately	NULL
60	NULL
%	NULL
and	NULL
40	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
circulating	NULL
adult	NULL
CD4	NULL
T	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
The	NULL
CD45RO*	NULL
subset	NULL
is	NULL
highly	NULL
enriched	NULL
in	NULL
functional	NULL
memory	NULL
T	NULL
cells	NULL
,	NULL
defined	NULL
by	NULL
their	NULL
enhanced	NULL
responses	NULL
to	NULL
recall	NULL
anti-gens	NULL
.	NULL

``	NULL
*	NULL
``	NULL
°	NULL
These	NULL
enhanced	NULL
responses	NULL
are	NULL
presumed	NULL
to	NULL
be	NULL
a	NULL
result	NULL
of	NULL
previous	NULL
activation	NULL
and	NULL
expansion	NULL
of	NULL
this	NULL
cell	NULL
population	NULL
in	NULL
vivo	NULL
in	NULL
response	NULL
to	NULL
cognate	NULL
antigen	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
CD45RA	NULL
*	NULL
cells	NULL
may	NULL
serve	NULL
as	NULL
the	NULL
precursors	NULL
of	NULL
the	NULL
primed	NULL
population	NULL
,	NULL
although	NULL
this	NULL
remains	NULL
a	NULL
point	NULL
of	NULL
controversy	NULL
.	NULL
``	NULL

Our	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
IL-13	NULL
gene	NULL
and	NULL
IL-4	NULL
genes	NULL
are	NULL
similar	NULL
in	NULL
that	NULL
priming	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
vivo	NULL
appears	NULL
to	NULL
upregu-late	NULL
their	NULL
capacity	NULL
to	NULL
express	NULL
these	NULL
two	NULL
cytokines	NULL
but	NULL
does	NULL
not	NULL
enhance	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
detectable	NULL
IL-13	NULL
or	NULL
IL-4	NULL
mRNA	NULL
expression	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
,	NULL
a	NULL
cell	NULL
population	NULL
that	NULL
presumably	NULL
has	NULL
had	NULL
insignificant	NULL
exposure	NULL
to	NULL
foreign	NULL
antigen	NULL
,	NULL
is	NULL
also	NULL
consistent	NULL
with	NULL
a	NULL
model	NULL
in	NULL
which	NULL
high	NULL
levels	NULL
of	NULL
IL-13	NULL
and	NULL
IL-4	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3324	NULL
gene	NULL
expression	NULL
depend	NULL
on	NULL
previous	NULL
T-cell	NULL
activation	NULL
in	NULL
vivo	NULL
.	NULL

The	NULL
surface	NULL
phenotype	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
is	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
CD45RA*CD4S5RO~	NULL
,	NULL
``	NULL
again	NULL
suggesting	NULL
that	NULL
this	NULL
pattern	NULL
of	NULL
surface	NULL
expression	NULL
of	NULL
CD45	NULL
isoforms	NULL
identifies	NULL
T-cell	NULL
populations	NULL
that	NULL
are	NULL
antigenically	NULL
naive	NULL
.	NULL

Because	NULL
IL-2	NULL
expression	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
was	NULL
similar	NULL
to	NULL
or	NULL
greater	NULL
than	NULL
that	NULL
by	NULL
adult	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
low	NULL
level	NULL
of	NULL
IL-13	NULL
mRNA	NULL
expression	NULL
by	NULL
this	NULL
cell	NULL
type	NULL
can	NULL
not	NULL
be	NULL
attributed	NULL
to	NULL
a	NULL
global	NULL
immaturity	NULL
in	NULL
its	NULL
capacity	NULL
to	NULL
produce	NULL
cytokines	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
observation	NULL
that	NULL
neonatal	NULL
CD4	NULL
T-cell	NULL
clones	NULL
were	NULL
routinely	NULL
able	NULL
to	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
IL-13	NULL
and	NULL
IL-4	NULL
mRNA	NULL
suggests	NULL
that	NULL
neonatal	NULL
CD4	NULL
T	NULL
cells	NULL
are	NULL
not	NULL
intrinsically	NULL
limited	NULL
in	NULL
their	NULL
capacity	NULL
to	NULL
express	NULL
these	NULL
cytokines	NULL
and	NULL
,	NULL
under	NULL
suitable	NULL
conditions	NULL
of	NULL
priming	NULL
in	NULL
vitro	NULL
and	NULL
,	NULL
presumably	NULL
,	NULL
in	NULL
vivo	NULL
,	NULL
can	NULL
acquire	NULL
the	NULL
capacity	NULL
to	NULL
express	NULL
both	NULL
IL-13	NULL
and	NULL
IL-4	NULL
at	NULL
high	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
found	NULL
in	NULL
adult	NULL
CD4	NULL
T-cell	NULL
clones	NULL
.	NULL

The	NULL
markedly	NULL
higher	NULL
levels	NULL
of	NULL
IL-13	NULL
and	NULL
IL-4	NULL
mRNA	NULL
in	NULL
adult	NULL
CD4	NULL
T-cell	NULL
clones	NULL
compared	NULL
with	NULL
those	NULL
in	NULL
freshly	NULL
isolated	NULL
adult	NULL
T	NULL
cells	NULL
suggests	NULL
that	NULL
priming	NULL
in	NULL
vitro	NULL
is	NULL
also	NULL
a	NULL
potent	NULL
inducer	NULL
in	NULL
this	NULL
cell	NULL
population	NULL
for	NULL
an	NULL
increased	NULL
capacity	NULL
to	NULL
express	NULL
these	NULL
cytokines	NULL
.	NULL

This	NULL
priming	NULL
model	NULL
is	NULL
supported	NULL
by	NULL
studies	NULL
showing	NULL
that	NULL
,	NULL
when	NULL
circulating	NULL
neonatal	NULL
T	NULL
cells	NULL
or	NULL
adult	NULL
CD45SRA*CD4	NULL
T	NULL
cells	NULL
are	NULL
propagated	NULL
in	NULL
bulk	NULL
for	NULL
short	NULL
periods	NULL
of	NULL
time	NULL
in	NULL
vitro	NULL
,	NULL
their	NULL
capacity	NULL
to	NULL
express	NULL
IL-4	NULL
mRNA	NULL
is	NULL
increased	NULL
,	NULL
whereas	NULL
IL-2	NULL
gene	NULL
expression	NULL
remains	NULL
un-changed	NULL
.	NULL
``	NULL

''	NULL
In	NULL
summary	NULL
,	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
are	NULL
located	NULL
a	NULL
short	NULL
distance	NULL
apart	NULL
,	NULL
increasing	NULL
the	NULL
possibility	NULL
that	NULL
these	NULL
two	NULL
cytokines	NULL
may	NULL
share	NULL
common	NULL
regulatory	NULL
regions	NULL
,	NULL
such	NULL
as	NULL
an	NULL
enhancer	NULL
.	NULL

It	NULL
is	NULL
plausible	NULL
that	NULL
additional	NULL
coregulated	NULL
cytokine	NULL
genes	NULL
may	NULL
reside	NULL
in	NULL
this	NULL
already	NULL
cyto-kine-rich	NULL
region	NULL
of	NULL
the	NULL
human	NULL
genome	NULL
.	NULL

The	NULL
IL-13	NULL
and	NULL
IL-4	NULL
promoters	NULL
appear	NULL
to	NULL
both	NULL
use	NULL
NF-AT-binding	NULL
P	NULL
elements	NULL
for	NULL
their	NULL
transcriptional	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
activation	NULL
.	NULL

Our	NULL
results	NULL
using	NULL
untransformed	NULL
human	NULL
T-cell	NULL
populations	NULL
support	NULL
the	NULL
results	NULL
of	NULL
earlier	NULL
studies	NULL
of	NULL
murine	NULL
CD4	NULL
T-cell	NULL
clones®	NULL
``	NULL
showing	NULL
that	NULL
the	NULL
IL-13	NULL
and	NULL
IL-4	NULL
genes	NULL
tend	NULL
to	NULL
be	NULL
coordinately	NULL
expressed	NULL
after	NULL
T-cell	NULL
activation	NULL
and	NULL
indicate	NULL
that	NULL
prior	NULL
activation	NULL
,	NULL
ie	NULL
,	NULL
priming	NULL
,	NULL
is	NULL
required	NULL
for	NULL
either	NULL
of	NULL
these	NULL
cytokines	NULL
to	NULL
be	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
by	NULL
T	NULL
cells	NULL
.	NULL

Because	NULL
NF-ATp	NULL
binding	NULL
activity	NULL
to	NULL
P	NULL
elements	NULL
is	NULL
higher	NULL
in	NULL
primed	NULL
T	NULL
cells	NULL
than	NULL
that	NULL
in	NULL
freshly	NULL
isolated	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
IL-13	NULL
and	NULL
IL-4	NULL
P	NULL
elements	NULL
could	NULL
mediate	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
the	NULL
coordinate	NULL
expression	NULL
of	NULL
these	NULL
two	NULL
cytokines	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
are	NULL
indebted	NULL
to	NULL
Drs	NULL
Anjana	NULL
Rao	NULL
(	NULL
Dana	NULL
Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
and	NULL
Christopher	NULL
Wilson	NULL
(	NULL
University	NULL
of	NULL
Washington	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
for	NULL
providing	NULL
reagents	NULL
,	NULL
to	NULL
Yu	NULL
Zhang	NULL
for	NULL
analyzing	NULL
Jurkat	NULL
cell	NULL
RNA	NULL
for	NULL
IL-13	NULL
transcripts	NULL
,	NULL
and	NULL
to	NULL
Dr	NULL
Randy	NULL
Cron	NULL
(	NULL
University	NULL
of	NULL
Washington	NULL
)	NULL
for	NULL
his	NULL
critique	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Paul	NULL
WE	NULL
,	NULL
Seder	NULL
RA	NULL
:	NULL
Lymphocyte	NULL
responses	NULL
and	NULL
cytokines	NULL
.	NULL

Cell	NULL
76:241	NULL
,	NULL
1994	NULL
2	NULL
.	NULL

Boulay	NULL
J-L	NULL
,	NULL
Paul	NULL
WE	NULL
:	NULL
The	NULL
interleukin-4-related	NULL
lymphokines	NULL
and	NULL
their	NULL
binding	NULL
to	NULL
hematopoietin	NULL
receptors	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:20525	NULL
,	NULL
1992	NULL
DOLGANOV	NULL
ET	NULL
AL	NULL
3	NULL
.	NULL

Saltman	NULL
DL	NULL
,	NULL
Dolganov	NULL
GM	NULL
,	NULL
Warrington	NULL
JA	NULL
,	NULL
Wasmuth	NULL
JJ	NULL
,	NULL
Lovett	NULL
M	NULL
:	NULL
A	NULL
physical	NULL
map	NULL
of	NULL
15	NULL
loci	NULL
on	NULL
human	NULL
chromosome	NULL
5q23-q33	NULL
by	NULL
two-color	NULL
fluorescence	NULL
in	NULL
site	NULL
hybridization	NULL
Genomics	NULL
16:726	NULL
,	NULL
1993	NULL
4	NULL
.	NULL

Morgan	NULL
JM	NULL
,	NULL
Doiganoy	NULL
GM	NULL
,	NULL
Robbins	NULL
SE	NULL
,	NULL
Hinton	NULL
LM	NULL
,	NULL
Lovett	NULL
M	NULL
:	NULL
The	NULL
selective	NULL
isolation	NULL
of	NULL
novel	NULL
cDNAs	NULL
encoded	NULL
by	NULL
the	NULL
regions	NULL
surrounding	NULL
the	NULL
human	NULL
interleukin	NULL
4	NULL
and	NULL
5	NULL
genes	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
20:5173	NULL
,	NULL
1992	NULL
5	NULL
.	NULL

McKenzie	NULL
ANJ	NULL
,	NULL
Li	NULL
X	NULL
,	NULL
Lagaespada	NULL
DA	NULL
,	NULL
Sato	NULL
A	NULL
,	NULL
Kaneda	NULL
A	NULL
,	NULL
Zurawski	NULL
SM	NULL
,	NULL
Doyle	NULL
EL	NULL
,	NULL
Milatovich	NULL
A	NULL
,	NULL
Francke	NULL
U	NULL
,	NULL
Copeland	NULL
NG	NULL
,	NULL
Jenkins	NULL
NA	NULL
,	NULL
Zurawski	NULL
G	NULL
:	NULL
Structural	NULL
comparison	NULL
and	NULL
chromosomal	NULL
localization	NULL
of	NULL
the	NULL
human	NULL
and	NULL
mouse	NULL
IL-13	NULL
genes	NULL
.	NULL

J	NULL
Immunol	NULL
150:5436	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Farrar	NULL
MA	NULL
,	NULL
Schreiber	NULL
RD	NULL
:	NULL
The	NULL
molecular	NULL
and	NULL
cell	NULL
biology	NULL
of	NULL
interferon-y	NULL
and	NULL
its	NULL
receptor	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
11:571	NULL
,	NULL
1993	NULL
7	NULL
.	NULL

Fletcher	NULL
M	NULL
,	NULL
Goldstein	NULL
AL	NULL
:	NULL
Recent	NULL
advances	NULL
in	NULL
the	NULL
understanding	NULL
of	NULL
the	NULL
biochemistry	NULL
and	NULL
clinical	NULL
pharmacology	NULL
of	NULL
interleukin-2	NULL
.	NULL

Lymphokine	NULL
Res	NULL
6:45	NULL
,	NULL
1987	NULL
8	NULL
.	NULL

Cherwinski	NULL
H	NULL
,	NULL
Schumacher	NULL
JH	NULL
,	NULL
Brown	NULL
KD	NULL
,	NULL
Mosmann	NULL
TR	NULL
:	NULL
Two	NULL
types	NULL
of	NULL
mouse	NULL
helper	NULL
T	NULL
cell	NULL
clone	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
166:1229	NULL
,	NULL
1987	NULL
9	NULL
.	NULL

Brown	NULL
KD	NULL
,	NULL
Zurawski	NULL
SM	NULL
,	NULL
Mosmann	NULL
TR	NULL
,	NULL
Zurawski	NULL
GL	NULL
:	NULL
A	NULL
family	NULL
of	NULL
small	NULL
inducible	NULL
proteins	NULL
secreted	NULL
by	NULL
leukocytes	NULL
are	NULL
members	NULL
of	NULL
a	NULL
new	NULL
superfamily	NULL
that	NULL
includes	NULL
leukocyte	NULL
and	NULL
fibroblast-derived	NULL
inflammatory	NULL
agents	NULL
,	NULL
growth	NULL
factors	NULL
,	NULL
and	NULL
indicators	NULL
of	NULL
various	NULL
activation	NULL
processes	NULL
.	NULL

J	NULL
Immunol	NULL
142:679	NULL
,	NULL
1989	NULL
10	NULL
.	NULL

Zurawski	NULL
SM	NULL
,	NULL
Vega	NULL
F	NULL
Jr	NULL
,	NULL
Buyghe	NULL
B	NULL
,	NULL
Zurawski	NULL
G	NULL
:	NULL
Receptors	NULL
for	NULL
interleukin-13	NULL
and	NULL
interleukin-4	NULL
are	NULL
complex	NULL
and	NULL
share	NULL
a	NULL
novel	NULL
component	NULL
that	NULL
functions	NULL
in	NULL
signal	NULL
transduction	NULL
.	NULL

EMBO	NULL
J	NULL
12:2663	NULL
,	NULL
1993	NULL
11	NULL
.	NULL

Minty	NULL
A	NULL
,	NULL
Chalon	NULL
P	NULL
,	NULL
Derocq	NULL
JM	NULL
,	NULL
Dumont	NULL
X	NULL
,	NULL
Guillemot	NULL
J-C	NULL
,	NULL
Kaghad	NULL
M	NULL
,	NULL
Labit	NULL
C	NULL
,	NULL
Leplatois	NULL
P	NULL
,	NULL
Liauzyn	NULL
P	NULL
,	NULL
Miloux	NULL
B	NULL
,	NULL
Minty	NULL
C	NULL
,	NULL
Casellas	NULL
P	NULL
,	NULL
Loison	NULL
G	NULL
,	NULL
Kupker	NULL
J	NULL
,	NULL
Shire	NULL
D	NULL
,	NULL
Ferrara	NULL
P	NULL
,	NULL
Caput	NULL
D	NULL
:	NULL
Interleukin-13	NULL
is	NULL
a	NULL
new	NULL
human	NULL
lymphokine	NULL
regulating	NULL
inflammatory	NULL
and	NULL
immune	NULL
responses	NULL
.	NULL

Nature	NULL
362:248	NULL
,	NULL
1993	NULL
12	NULL
.	NULL

Punnonen	NULL
J	NULL
,	NULL
Aversa	NULL
G	NULL
,	NULL
Cocks	NULL
BG	NULL
,	NULL
McKenzie	NULL
ANJ	NULL
,	NULL
Menon	NULL
S	NULL
,	NULL
Zurawski	NULL
G	NULL
,	NULL
Malefyt	NULL
RW	NULL
,	NULL
de	NULL
Vries	NULL
JE	NULL
:	NULL
Interleukin	NULL
13	NULL
induces	NULL
interleukin	NULL
4-independent	NULL
IgG4	NULL
and	NULL
IgE	NULL
synthesis	NULL
and	NULL
CD23	NULL
expression	NULL
by	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:3730	NULL
,	NULL
1993	NULL
13	NULL
.	NULL

McKenzie	NULL
ANJ	NULL
,	NULL
Culpepper	NULL
JA	NULL
,	NULL
Malefyt	NULL
RAW	NULL
,	NULL
Briere	NULL
F	NULL
,	NULL
Punnonen	NULL
J	NULL
,	NULL
Aversa	NULL
G	NULL
,	NULL
Sato	NULL
A	NULL
,	NULL
Dang	NULL
W	NULL
,	NULL
Cocks	NULL
BG	NULL
,	NULL
Menon	NULL
S	NULL
,	NULL
de	NULL
Vries	NULL
JE	NULL
,	NULL
Banchereau	NULL
J	NULL
,	NULL
Zurawski	NULL
G	NULL
:	NULL
Interleukin	NULL
13	NULL
,	NULL
a	NULL
T-cell-derived	NULL
cytokine	NULL
that	NULL
regulates	NULL
human	NULL
monocyte	NULL
and	NULL
B-cell	NULL
function	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:3735	NULL
,	NULL
1993	NULL
14	NULL
.	NULL

Cocks	NULL
BG	NULL
,	NULL
Malefyt	NULL
RdW	NULL
,	NULL
Galizzi	NULL
J-P	NULL
,	NULL
deVries	NULL
JE	NULL
,	NULL
Aversa	NULL
G	NULL
:	NULL
IL-13	NULL
induces	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
human	NULL
B	NULL
cells	NULL
activated	NULL
by	NULL
the	NULL
CD40	NULL
ligand	NULL
.	NULL

Int	NULL
Immunol	NULL
5:657	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Defrance	NULL
T	NULL
,	NULL
Carayon	NULL
P	NULL
,	NULL
Billian	NULL
G	NULL
,	NULL
Guillemot	NULL
J-C	NULL
,	NULL
Minty	NULL
A	NULL
,	NULL
Caput	NULL
D	NULL
,	NULL
Ferrara	NULL
P	NULL
:	NULL
Interleukin	NULL
13	NULL
is	NULL
a	NULL
B	NULL
cell	NULL
stimulating	NULL
factor	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
179:135	NULL
,	NULL
1994	NULL
16	NULL
.	NULL

Malefyt	NULL
RdW	NULL
,	NULL
Figdor	NULL
C	NULL
,	NULL
Huijbens	NULL
R	NULL
,	NULL
Mohan-Peterson	NULL
S	NULL
,	NULL
Bennett	NULL
B	NULL
,	NULL
Culpepper	NULL
J	NULL
,	NULL
Dang	NULL
W	NULL
,	NULL
Zurawski	NULL
G	NULL
,	NULL
de	NULL
Vries	NULL
JE	NULL
:	NULL
Effect	NULL
of	NULL
IL-13	NULL
on	NULL
phenotype	NULL
,	NULL
cytokine	NULL
production	NULL
,	NULL
and	NULL
cytotoxic	NULL
function	NULL
of	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Immunol	NULL
151:6370	NULL
,	NULL
1993	NULL
17	NULL
.	NULL

Musso	NULL
T	NULL
,	NULL
Varesio	NULL
L	NULL
,	NULL
Zhang	NULL
X	NULL
,	NULL
Rowe	NULL
TK	NULL
,	NULL
Ferrara	NULL
P	NULL
,	NULL
Ortaldo	NULL
JR	NULL
,	NULL
O'Shea	NULL
JJ	NULL
,	NULL
McVicar	NULL
DW	NULL
:	NULL
IL-4	NULL
and	NULL
IL-13	NULL
induce	NULL
Lsk	NULL
,	NULL
a	NULL
Csk-like	NULL
tyrosine	NULL
kinase	NULL
,	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
180:2328	NULL
,	NULL
1994	NULL
18	NULL
.	NULL

Bochner	NULL
BS	NULL
,	NULL
Klunk	NULL
DA	NULL
,	NULL
Sterbinsky	NULL
SA	NULL
,	NULL
Coffman	NULL
RL	NULL
,	NULL
Schleimer	NULL
RP	NULL
:	NULL
IL-13	NULL
selectively	NULL
induces	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
expression	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
154:799	NULL
,	NULL
1995	NULL
19	NULL
.	NULL

Sironi	NULL
M	NULL
,	NULL
Sciacca	NULL
FL	NULL
,	NULL
Matteucci	NULL
C	NULL
,	NULL
Conni	NULL
M	NULL
,	NULL
Becchi	NULL
A	NULL
,	NULL
Bernasconi	NULL
S	NULL
,	NULL
Minty	NULL
A	NULL
,	NULL
Caput	NULL
D	NULL
,	NULL
Ferrara	NULL
P	NULL
,	NULL
Colotta	NULL
F	NULL
,	NULL
Mantovani	NULL
A	NULL
:	NULL
Regulation	NULL
of	NULL
endothelial	NULL
and	NULL
mesothelial	NULL
function	NULL
by	NULL
interleukin	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

COEXPRESSION	NULL
OF	NULL
IL-4	NULL
AND	NULL
IL-13	NULL
13	NULL
:	NULL
Selective	NULL
induction	NULL
of	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
and	NULL
amplification	NULL
of	NULL
interleukin-6	NULL
production	NULL
.	NULL

Blood	NULL
84:1913	NULL
,	NULL
1994	NULL
20	NULL
.	NULL

Zurawksi	NULL
G	NULL
,	NULL
de	NULL
Vries	NULL
JE	NULL
:	NULL
Interleukin	NULL
13	NULL
,	NULL
an	NULL
interleukin-4-like	NULL
cytokine	NULL
that	NULL
acts	NULL
on	NULL
monocytes	NULL
and	NULL
B	NULL
cells	NULL
,	NULL
but	NULL
not	NULL
on	NULL
T	NULL
cells	NULL
.	NULL

Immunol	NULL
Today	NULL
15:19	NULL
,	NULL
1994	NULL
21	NULL
.	NULL

Obiri	NULL
NI	NULL
,	NULL
Debinski	NULL
W	NULL
,	NULL
Leonard	NULL
WJ	NULL
,	NULL
Puri	NULL
RK	NULL
:	NULL
Receptor	NULL
for	NULL
interleukin	NULL
13	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
27:8797	NULL
,	NULL
1995	NULL
22	NULL
.	NULL

Lin	NULL
J-X	NULL
,	NULL
Migone	NULL
T-S	NULL
,	NULL
Tsand	NULL
M	NULL
,	NULL
Friedmann	NULL
M	NULL
,	NULL
Weatherbee	NULL
JA	NULL
,	NULL
Zhou	NULL
L	NULL
,	NULL
Yamauchi	NULL
A	NULL
,	NULL
Bloom	NULL
ET	NULL
,	NULL
Mietz	NULL
J	NULL
,	NULL
John	NULL
$	NULL
,	NULL
Leonard	NULL
W	NULL
:	NULL
The	NULL
role	NULL
of	NULL
shared	NULL
receptor	NULL
motifs	NULL
and	NULL
common	NULL
stat	NULL
proteins	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
cytokine	NULL
pleiotropy	NULL
and	NULL
redundancy	NULL
by	NULL
IL-2	NULL
,	NULL
IL-4	NULL
,	NULL
IL-7	NULL
,	NULL
IL-13	NULL
,	NULL
and	NULL
IL-15	NULL
.	NULL

Immunity	NULL
2:331	NULL
,	NULL
1995	NULL
23	NULL
.	NULL

Jacobsen	NULL
SEW	NULL
,	NULL
Okkenhaug	NULL
C	NULL
,	NULL
Veiby	NULL
OP	NULL
,	NULL
Caput	NULL
D	NULL
,	NULL
Ferrara	NULL
P	NULL
,	NULL
Minty	NULL
A	NULL
:	NULL
Interleukin	NULL
13	NULL
:	NULL
Novel	NULL
role	NULL
in	NULL
direct	NULL
regulation	NULL
of	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
primitive	NULL
hematopoietic	NULL
progenitor	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
180:75	NULL
,	NULL
1994	NULL
24	NULL
.	NULL

Wynn	NULL
TA	NULL
,	NULL
Oswald	NULL
IP	NULL
,	NULL
Eltoum	NULL
IA	NULL
,	NULL
Caspar	NULL
P	NULL
,	NULL
Lowenstein	NULL
CJ	NULL
,	NULL
Lewis	NULL
FA	NULL
,	NULL
James	NULL
SL	NULL
,	NULL
Sher	NULL
A	NULL
:	NULL
Elevated	NULL
expression	NULL
of	NULL
Th1	NULL
cytokines	NULL
and	NULL
nitric	NULL
oxide	NULL
synthase	NULL
in	NULL
the	NULL
lungs	NULL
of	NULL
vaccinated	NULL
mice	NULL
after	NULL
challenge	NULL
infection	NULL
with	NULL
Schistoma	NULL
mansoni	NULL
.	NULL

J	NULL
Immunol	NULL
153:5200	NULL
,	NULL
1994	NULL
25	NULL
.	NULL

Lovett	NULL
M	NULL
,	NULL
Kere	NULL
J	NULL
,	NULL
Hinton	NULL
LM	NULL
:	NULL
Direct	NULL
selection	NULL
:	NULL
A	NULL
method	NULL
for	NULL
the	NULL
isolation	NULL
of	NULL
cDNAs	NULL
encoded	NULL
by	NULL
large	NULL
genomic	NULL
regions	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
88:9628	NULL
,	NULL
1991	NULL
26	NULL
.	NULL

Gilliam	NULL
TC	NULL
,	NULL
Freimer	NULL
NB	NULL
,	NULL
Kaufmann	NULL
CA	NULL
,	NULL
Powchik	NULL
PP	NULL
:	NULL
Deletion	NULL
mapping	NULL
of	NULL
DNA	NULL
markers	NULL
to	NULL
a	NULL
region	NULL
of	NULL
chromosome	NULL
5	NULL
that	NULL
cosegregates	NULL
with	NULL
schizophrenia	NULL
.	NULL

Genomics	NULL
5:940	NULL
,	NULL
1989	NULL
27	NULL
.	NULL

Burke	NULL
DT	NULL
,	NULL
Carle	NULL
GF	NULL
,	NULL
Olson	NULL
MV	NULL
:	NULL
Cloning	NULL
of	NULL
large	NULL
segments	NULL
of	NULL
exogenous	NULL
DNA	NULL
in	NULL
yeast	NULL
by	NULL
means	NULL
of	NULL
artificial	NULL
chromosome	NULL
clones	NULL
.	NULL

Science	NULL
236:806	NULL
,	NULL
1987	NULL
28	NULL
.	NULL

Longmire	NULL
JL	NULL
,	NULL
Brown	NULL
NC	NULL
,	NULL
Meincke	NULL
LJ	NULL
,	NULL
Campbell	NULL
ML	NULL
,	NULL
Al-bright	NULL
KL	NULL
,	NULL
Fawcett	NULL
JJ	NULL
,	NULL
Campbell	NULL
EW	NULL
,	NULL
Moyzis	NULL
RK	NULL
,	NULL
Hildebrand	NULL
CE	NULL
,	NULL
Evans	NULL
GA	NULL
,	NULL
Deaven	NULL
,	NULL
LL	NULL
:	NULL
Construction	NULL
and	NULL
characterization	NULL
of	NULL
partial	NULL
digest	NULL
DNA	NULL
libraries	NULL
made	NULL
from	NULL
flow-sorted	NULL
human	NULL
chromosome	NULL
16	NULL
.	NULL

Genet	NULL
Anal	NULL
Tech	NULL
Appl	NULL
10:69	NULL
,	NULL
1993	NULL
29	NULL
.	NULL

Horton	NULL
RM	NULL
,	NULL
Cai	NULL
Z	NULL
,	NULL
Ho	NULL
SN	NULL
,	NULL
Pease	NULL
LR	NULL
:	NULL
Gene	NULL
splicing	NULL
by	NULL
overlap	NULL
extension	NULL
:	NULL
Tailor-made	NULL
genes	NULL
using	NULL
the	NULL
polymerase	NULL
chain	NULL
reaction	NULL
.	NULL

Biotechniques	NULL
8:528	NULL
,	NULL
1990	NULL
30	NULL
.	NULL

Penix	NULL
L	NULL
,	NULL
Weaver	NULL
WM	NULL
,	NULL
Pang	NULL
Y	NULL
,	NULL
Young	NULL
HA	NULL
,	NULL
Wilson	NULL
CB	NULL
:	NULL
Two	NULL
essential	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
interferon-y	NULL
promoter	NULL
confer	NULL
activation	NULL
specific	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
178:1483	NULL
,	NULL
1993	NULL
31	NULL
.	NULL

Lewis	NULL
DB	NULL
,	NULL
Yu	NULL
CC	NULL
,	NULL
Meyer	NULL
J	NULL
,	NULL
English	NULL
BK	NULL
,	NULL
Kahn	NULL
SJ	NULL
,	NULL
Wilson	NULL
CB	NULL
:	NULL
Cellular	NULL
and	NULL
molecular	NULL
mechanisms	NULL
for	NULL
reduced	NULL
interleukin	NULL
4	NULL
and	NULL
interferon-y	NULL
production	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
§7:194	NULL
,	NULL
1991	NULL
32	NULL
.	NULL

Rose	NULL
LM	NULL
,	NULL
Ginsberg	NULL
AH	NULL
,	NULL
Rothstein	NULL
TL	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Clark	NULL
EA	NULL
:	NULL
Selective	NULL
loss	NULL
of	NULL
a	NULL
subset	NULL
of	NULL
T	NULL
helper	NULL
cells	NULL
in	NULL
active	NULL
multiple	NULL
sclerosis	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
82:7389	NULL
,	NULL
1985	NULL
33	NULL
.	NULL

Hu-Li	NULL
J	NULL
,	NULL
O'Hara	NULL
J	NULL
,	NULL
Watson	NULL
C	NULL
,	NULL
Tsang	NULL
W	NULL
,	NULL
Paul	NULL
WE	NULL
:	NULL
Derivation	NULL
of	NULL
a	NULL
T	NULL
cell	NULL
line	NULL
that	NULL
is	NULL
highly	NULL
responsive	NULL
to	NULL
IL-4	NULL
and	NULL
IL-2	NULL
(	NULL
CT-4R	NULL
)	NULL
and	NULL
of	NULL
an	NULL
IL-2	NULL
hyporesponsive	NULL
mutant	NULL
of	NULL
that	NULL
line	NULL
(	NULL
CT.4S	NULL
)	NULL
.	NULL

J	NULL
Immunol	NULL
142:800	NULL
,	NULL
1989	NULL
34	NULL
.	NULL

McCaffrey	NULL
PG	NULL
,	NULL
Luo	NULL
C	NULL
,	NULL
Kerppola	NULL
TK	NULL
,	NULL
Jain	NULL
J	NULL
,	NULL
Badalian	NULL
TM	NULL
,	NULL
Ho	NULL
AM	NULL
,	NULL
Burgeon	NULL
E	NULL
,	NULL
Lane	NULL
WS	NULL
,	NULL
Lambert	NULL
JN	NULL
,	NULL
Curran	NULL
T	NULL
,	NULL
Verdine	NULL
GL	NULL
,	NULL
Rao	NULL
A	NULL
,	NULL
Hogan	NULL
PG	NULL
:	NULL
Isolation	NULL
of	NULL
the	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
262:750	NULL
,	NULL
1993	NULL
35	NULL
.	NULL

Arai	NULL
N	NULL
,	NULL
Nomura	NULL
D	NULL
,	NULL
Villaret	NULL
D	NULL
,	NULL
Malefijt	NULL
RD	NULL
,	NULL
Seiki	NULL
M	NULL
,	NULL
Yoshida	NULL
M	NULL
,	NULL
Minoshima	NULL
S	NULL
,	NULL
Fukuyama	NULL
R	NULL
,	NULL
Maekawa	NULL
M	NULL
,	NULL
Kudoh	NULL
J	NULL
,	NULL
Shimizu	NULL
N	NULL
,	NULL
Yokota	NULL
K	NULL
,	NULL
Abe	NULL
E	NULL
,	NULL
Yokota	NULL
T	NULL
,	NULL
Takebe	NULL
Y	NULL
,	NULL
Arai	NULL
K	NULL
:	NULL
Complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
chromosomal	NULL
gene	NULL
for	NULL
human	NULL
IL-4	NULL
and	NULL
its	NULL
expression	NULL
.	NULL

J	NULL
Immunol	NULL
142:274	NULL
,	NULL
1989	NULL
36	NULL
.	NULL

Glisin	NULL
V	NULL
,	NULL
Crkvenjakov	NULL
R	NULL
,	NULL
Byus	NULL
C	NULL
:	NULL
Ribonucleic	NULL
acid	NULL
isolated	NULL
by	NULL
cesium	NULL
chloride	NULL
centrifugation	NULL
.	NULL

Biochemistry	NULL
13:2633	NULL
,	NULL
1974	NULL
37	NULL
.	NULL

Chomezynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single	NULL
step	NULL
method	NULL
of	NULL
RNA	NULL
isola-	NULL
3325	NULL
tion	NULL
by	NULL
acid	NULL
guanidinium	NULL
thiocyanate-phenol-chloroform	NULL
extraction	NULL
.	NULL

Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1987	NULL
38	NULL
.	NULL

Lewis	NULL
DB	NULL
,	NULL
Prickett	NULL
KS	NULL
,	NULL
Larsen	NULL
A	NULL
,	NULL
Grabstein	NULL
K	NULL
,	NULL
Weaver	NULL
M	NULL
,	NULL
Wilson	NULL
C	NULL
:	NULL
Restricted	NULL
production	NULL
of	NULL
interleukin	NULL
4	NULL
by	NULL
activated	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:9743	NULL
,	NULL
1988	NULL
39	NULL
.	NULL

Feinberg	NULL
AP	NULL
,	NULL
Vogelstein	NULL
B	NULL
:	NULL
A	NULL
technique	NULL
for	NULL
radiolabeling	NULL
DNA	NULL
restriction	NULL
endonuclease	NULL
fragments	NULL
to	NULL
high	NULL
specific	NULL
activity	NULL
.	NULL

Anal	NULL
Biochem	NULL
132:6	NULL
,	NULL
1983	NULL
40	NULL
.	NULL

Antequera	NULL
F	NULL
,	NULL
Bird	NULL
A	NULL
:	NULL
CpG	NULL
islands	NULL
,	NULL
in	NULL
Jost	NULL
JP	NULL
,	NULL
Saluz	NULL
HP	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
DNA	NULL
Methylation	NULL
:	NULL
Molecular	NULL
Biology	NULL
and	NULL
Biological	NULL
Significance	NULL
.	NULL

Basel	NULL
,	NULL
Switzerland	NULL
,	NULL
Birkhauser	NULL
Verlag	NULL
,	NULL
1993	NULL
,	NULL
p	NULL
169	NULL
41	NULL
.	NULL

Sachs	NULL
AB	NULL
:	NULL
Messenger	NULL
RNA	NULL
degradation	NULL
in	NULL
eukaryotes	NULL
.	NULL

Cell	NULL
74:413	NULL
,	NULL
1993	NULL
42	NULL
.	NULL

Abe	NULL
E	NULL
,	NULL
Malefyt	NULL
RDW	NULL
,	NULL
Matsuda	NULL
I	NULL
,	NULL
Arai	NULL
K	NULL
,	NULL
Arai	NULL
N	NULL
:	NULL
An	NULL
11-base-pair	NULL
DNA	NULL
sequence	NULL
motif	NULL
apparently	NULL
unique	NULL
to	NULL
the	NULL
human	NULL
interleukin	NULL
4	NULL
gene	NULL
confers	NULL
responsiveness	NULL
to	NULL
T-cell	NULL
activation	NULL
signals	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
89:2864	NULL
,	NULL
1992	NULL
43	NULL
.	NULL

Szabo	NULL
SJ	NULL
,	NULL
Gold	NULL
JS	NULL
,	NULL
Murphy	NULL
TL	NULL
,	NULL
Murphy	NULL
KM	NULL
:	NULL
Identification	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
controlling	NULL
interleukin-4	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
:	NULL
Roles	NULL
for	NULL
NF-Y	NULL
and	NULL
NF-ATc	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:4793	NULL
,	NULL
1993	NULL
44	NULL
.	NULL

Rooney	NULL
JW	NULL
,	NULL
Hoey	NULL
T	NULL
,	NULL
Glimcher	NULL
LH	NULL
:	NULL
Coordinate	NULL
and	NULL
cooperative	NULL
roles	NULL
for	NULL
NF-AT	NULL
and	NULL
AP-1	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
.	NULL

Immunity	NULL
2:473	NULL
,	NULL
1995	NULL
45	NULL
.	NULL

Rooney	NULL
JW	NULL
,	NULL
Hodge	NULL
MR	NULL
,	NULL
McCaffrey	NULL
P	NULL
,	NULL
Rao	NULL
A	NULL
,	NULL
Glimcher	NULL
L	NULL
:	NULL
A	NULL
common	NULL
factor	NULL
regulates	NULL
both	NULL
Thi-	NULL
and	NULL
Th2-specific	NULL
cytokine	NULL
gene	NULL
expression	NULL
.	NULL

EMBO	NULL
J	NULL
13:625	NULL
,	NULL
1994	NULL
46	NULL
.	NULL

Kubo	NULL
M	NULL
,	NULL
Kincaid	NULL
RL	NULL
,	NULL
Webb	NULL
DR	NULL
,	NULL
Ransom	NULL
JT	NULL
:	NULL
The	NULL
Ca**/	NULL
calmodulin-activated	NULL
phosphoprotein	NULL
phsophatase	NULL
calcineurin	NULL
is	NULL
sufficient	NULL
for	NULL
positive	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
mouse	NULL
IL-4	NULL
gene	NULL
.	NULL

Int	NULL
Immunol	NULL
6:179	NULL
,	NULL
1994	NULL
47	NULL
.	NULL

Tara	NULL
D	NULL
,	NULL
Weiss	NULL
DL	NULL
,	NULL
Brown	NULL
MA	NULL
:	NULL
An	NULL
activation-responsive	NULL
element	NULL
in	NULL
the	NULL
murine	NULL
IL-4	NULL
gene	NULL
is	NULL
the	NULL
site	NULL
of	NULL
an	NULL
inducible	NULL
DNA-protein	NULL
interaction	NULL
.	NULL

J	NULL
Immunol	NULL
151:3617	NULL
,	NULL
1993	NULL
48	NULL
.	NULL

Bruhn	NULL
KW	NULL
,	NULL
Nelms	NULL
K	NULL
,	NULL
Boulay	NULL
J-L	NULL
,	NULL
Paul	NULL
WE	NULL
,	NULL
Lenardo	NULL
MJ	NULL
:	NULL
Molecular	NULL
dissection	NULL
of	NULL
the	NULL
mouse	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
90:9707	NULL
,	NULL
1993	NULL
49	NULL
.	NULL

Malefyt	NULL
RW	NULL
,	NULL
Abrams	NULL
JS	NULL
,	NULL
de	NULL
Vries	NULL
JE	NULL
,	NULL
Yssel	NULL
H	NULL
;	NULL
IL-13	NULL
,	NULL
an	NULL
IL-4	NULL
like	NULL
cytokine	NULL
that	NULL
has	NULL
no	NULL
T	NULL
cell	NULL
stimulating	NULL
activities	NULL
,	NULL
is	NULL
produced	NULL
by	NULL
human	NULL
CD4+	NULL
and	NULL
CD8+	NULL
T	NULL
cells	NULL
and	NULL
CD4+	NULL
ThO	NULL
,	NULL
Th1	NULL
,	NULL
and	NULL
Th2	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

J	NULL
Cell	NULL
Biochem	NULL
18D:353	NULL
,	NULL
1994	NULL
50	NULL
.	NULL

Rao	NULL
A	NULL
:	NULL
NFATp	NULL
,	NULL
a	NULL
cyclosporin-sensitive	NULL
transcription	NULL
factor	NULL
implicated	NULL
in	NULL
cytokine	NULL
gene	NULL
induction	NULL
.	NULL

J	NULL
Leukoc	NULL
Biol	NULL
57:536	NULL
,	NULL
1995	NULL
51	NULL
.	NULL

Salmon	NULL
M	NULL
,	NULL
Kitas	NULL
GD	NULL
,	NULL
Bacon	NULL
PA	NULL
:	NULL
Production	NULL
of	NULL
lymphokine	NULL
mRNA	NULL
by	NULL
CD45R*	NULL
and	NULL
CD4SR	NULL
:	NULL
helper	NULL
T	NULL
cells	NULL
from	NULL
human	NULL
peripheral	NULL
blood	NULL
and	NULL
by	NULL
human	NULL
CD4*	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

J	NULL
Immunol	NULL
143:907	NULL
,	NULL
1989	NULL
52	NULL
.	NULL

Lewis	NULL
DB	NULL
,	NULL
Bort	NULL
SJ	NULL
:	NULL
Nuclear	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
P-element	NULL
of	NULL
the	NULL
human	NULL
interleukin-4	NULL
gene	NULL
promoter	NULL
in	NULL
primed/	NULL
memory	NULL
and	NULL
unprimed/antigenically-naive	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Cell	NULL
Biochem	NULL
18D:417	NULL
,	NULL
1994	NULL
53	NULL
.	NULL

Rivera	NULL
MC	NULL
,	NULL
Lake	NULL
JA	NULL
:	NULL
Evidence	NULL
that	NULL
eukaryotes	NULL
and	NULL
eoscyte	NULL
prokaryotes	NULL
are	NULL
immediate	NULL
relatives	NULL
.	NULL

Science	NULL
257:74	NULL
,	NULL
1992	NULL
54	NULL
.	NULL

Akbar	NULL
AN	NULL
,	NULL
Terry	NULL
L	NULL
,	NULL
Timms	NULL
A	NULL
,	NULL
Beverley	NULL
PCL	NULL
,	NULL
Janossy	NULL
G	NULL
:	NULL
Loss	NULL
of	NULL
CD45R	NULL
and	NULL
gain	NULL
of	NULL
UCHL1	NULL
activity	NULL
is	NULL
a	NULL
feature	NULL
of	NULL
primed	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
140:2171	NULL
,	NULL
1988	NULL
55	NULL
.	NULL

Sanders	NULL
ME	NULL
,	NULL
Makgova	NULL
MW	NULL
,	NULL
Sharrow	NULL
SO	NULL
,	NULL
Stephany	NULL
D	NULL
,	NULL
Springer	NULL
TA	NULL
,	NULL
Young	NULL
HA	NULL
,	NULL
Shaw	NULL
S	NULL
:	NULL
Human	NULL
memory	NULL
T	NULL
lymphocytes	NULL
express	NULL
increased	NULL
levels	NULL
of	NULL
three	NULL
cell	NULL
adhesion	NULL
molecules	NULL
(	NULL
LFA-3	NULL
,	NULL
CD2	NULL
and	NULL
LFA-1	NULL
)	NULL
and	NULL
three	NULL
other	NULL
molecules	NULL
(	NULL
UCHL-1	NULL
,	NULL
CDw29	NULL
and	NULL
Pgp-1	NULL
)	NULL
and	NULL
have	NULL
enhanced	NULL
IFN-y	NULL
production	NULL
.	NULL

J	NULL
Immunol	NULL
140:1401	NULL
,	NULL
1988	NULL
56	NULL
.	NULL

Beverly	NULL
PCL	NULL
,	NULL
Daser	NULL
A	NULL
,	NULL
Michie	NULL
CA	NULL
,	NULL
Wallace	NULL
DL	NULL
:	NULL
Functional	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
defined	NULL
by	NULL
isoforms	NULL
of	NULL
CD45	NULL
.	NULL

Biochem	NULL
Soc	NULL
Trans	NULL
20:184	NULL
,	NULL
1992	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

3326	NULL
57	NULL
.	NULL

Westbrook	NULL
CA	NULL
,	NULL
Neuman	NULL
WL	NULL
,	NULL
McPherson	NULL
J	NULL
,	NULL
Camper	NULL
S	NULL
,	NULL
Wasmuth	NULL
J	NULL
,	NULL
Plaetke	NULL
R	NULL
,	NULL
Williamson	NULL
R	NULL
:	NULL
Report	NULL
of	NULL
the	NULL
Second	NULL
International	NULL
Workshop	NULL
on	NULL
Human	NULL
Chromosome	NULL
5	NULL
.	NULL

Cytogenet	NULL
Cell	NULL
Genet	NULL
61:225	NULL
,	NULL
1992	NULL
58	NULL
.	NULL

Yang	NULL
YC	NULL
,	NULL
Kovacic	NULL
S	NULL
,	NULL
Friz	NULL
R	NULL
,	NULL
Wolf	NULL
S	NULL
,	NULL
Clark	NULL
SC	NULL
,	NULL
Wellems	NULL
TE	NULL
,	NULL
Nienhuis	NULL
A	NULL
,	NULL
Epstein	NULL
N	NULL
:	NULL
The	NULL
human	NULL
genes	NULL
for	NULL
GM-CSF	NULL
and	NULL
IL3	NULL
are	NULL
closely	NULL
linked	NULL
in	NULL
tandem	NULL
on	NULL
chromosome	NULL
5	NULL
.	NULL

Blood	NULL
71:958	NULL
,	NULL
1988	NULL
59	NULL
.	NULL

Cockerill	NULL
PN	NULL
,	NULL
Shannon	NULL
MF	NULL
,	NULL
Bert	NULL
AG	NULL
,	NULL
Ryan	NULL
GR	NULL
,	NULL
Vadas	NULL
M	NULL
:	NULL
The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor/interleukin	NULL
3	NULL
locus	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
inducible	NULL
cyclosporin	NULL
A-sensitive	NULL
enhancer	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:2466	NULL
,	NULL
1993	NULL
60	NULL
.	NULL

Larsen	NULL
F	NULL
,	NULL
Gundersen	NULL
G	NULL
,	NULL
Lopez	NULL
R	NULL
,	NULL
Prydz	NULL
H	NULL
:	NULL
CpG	NULL
islands	NULL
as	NULL
gene	NULL
markers	NULL
in	NULL
the	NULL
human	NULL
genome	NULL
.	NULL

Genomics	NULL
13:1095	NULL
,	NULL
1992	NULL
61	NULL
.	NULL

Chuvpilo	NULL
S	NULL
,	NULL
Schomberg	NULL
C	NULL
,	NULL
Gerwig	NULL
R	NULL
,	NULL
Heinfling	NULL
A	NULL
,	NULL
Reeves	NULL
R	NULL
,	NULL
Grummt	NULL
F	NULL
,	NULL
Serfling	NULL
E	NULL
:	NULL
Multiple	NULL
closely-linked	NULL
NFAT/octamer	NULL
DOLGANOV	NULL
ET	NULL
AL	NULL
and	NULL
HMG	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
binding	NULL
sites	NULL
are	NULL
part	NULL
of	NULL
the	NULL
interleukin-4	NULL
promoter	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
21:5694	NULL
,	NULL
1993	NULL
62	NULL
.	NULL

Kronke	NULL
M	NULL
,	NULL
Leonard	NULL
WJ	NULL
,	NULL
Depper	NULL
JM	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Sequential	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
human	NULL
T	NULL
lymphocyte	NULL
growth	NULL
and	NULL
differentiation	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
161:1593	NULL
,	NULL
1985	NULL
63	NULL
.	NULL

Yokota	NULL
T	NULL
,	NULL
Otsuka	NULL
T	NULL
,	NULL
Mosmann	NULL
T.	NULL
,	NULL
Banchereau	NULL
J	NULL
,	NULL
DeFrance	NULL
T	NULL
,	NULL
Blanchard	NULL
D	NULL
,	NULL
de	NULL
Vries	NULL
JD	NULL
,	NULL
Lee	NULL
F	NULL
,	NULL
Arai	NULL
K	NULL
:	NULL
Isolation	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
interleukin	NULL
cDNA	NULL
clone	NULL
,	NULL
homologous	NULL
to	NULL
mouse	NULL
B-cell	NULL
stimulatory	NULL
factor	NULL
2	NULL
,	NULL
that	NULL
expresses	NULL
B-cell	NULL
and	NULL
T-cell-stimulating	NULL
activities	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
83:5894	NULL
,	NULL
1986	NULL
64	NULL
.	NULL

Taniguchi	NULL
T	NULL
,	NULL
Matsui	NULL
H	NULL
,	NULL
Fujita	NULL
T	NULL
,	NULL
Takaoka	NULL
C	NULL
,	NULL
Kashima	NULL
N	NULL
,	NULL
Yoshimoto	NULL
R	NULL
,	NULL
Hamuro	NULL
J	NULL
:	NULL
Structure	NULL
and	NULL
expression	NULL
of	NULL
a	NULL
cloned	NULL
cDNA	NULL
for	NULL
human	NULL
interleukin-2	NULL
.	NULL

Nature	NULL
302:305	NULL
,	NULL
1983	NULL
65	NULL
.	NULL

Ehlers	NULL
S	NULL
,	NULL
Smith	NULL
KA	NULL
:	NULL
Differentiation	NULL
of	NULL
T	NULL
cell	NULL
lymphokine	NULL
gene	NULL
expression	NULL
:	NULL
The	NULL
in	NULL
vitro	NULL
acquisition	NULL
of	NULL
T	NULL
cell	NULL
memory	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
173:25	NULL
,	NULL
1991	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1996	NULL
87	NULL
:	NULL
3316-3326	NULL
Coexpression	NULL
of	NULL
the	NULL
interleukin-13	NULL
and	NULL
interleukin-4	NULL
genes	NULL
correlates	NULL
with	NULL
their	NULL
physical	NULL
linkage	NULL
in	NULL
the	NULL
cytokine	NULL
gene	NULL
cluster	NULL
on	NULL
human	NULL
chromosome	NULL
5q23-31	NULL
A	NULL
_	NULL
48	NULL
%	NULL
a	NULL
'	NULL
t	NULL
\se	NULL
@	NULL
.	NULL

®	NULL
~Oton®	NULL
/	NULL
{	NULL
®	NULL
G	NULL
Dolganov	NULL
,	NULL
S	NULL
Bort	NULL
,	NULL
M	NULL
Lovett	NULL
,	NULL
J	NULL
Burr	NULL
,	NULL
L	NULL
Schubert	NULL
,	NULL
D	NULL
Short	NULL
,	NULL
M	NULL
McGurn	NULL
,	NULL
C	NULL
Gibson	NULL
and	NULL
DB	NULL
Lewis	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/87/8/3316.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

